Cell signaling pathways as molecular targets to eliminate AML stem cells
•Acute myeloid leukemia remains the most lethal of leukemias.•Leukemic stem cells are associated with disease relapses.•Cell signaling pathways are targets to eliminate AML stem cells. Acute myeloid leukemia (AML) remains the most lethal of leukemias and a small population of cells called leukemic s...
Saved in:
Published in: | Critical reviews in oncology/hematology Vol. 160; p. 103277 |
---|---|
Main Authors: | , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Netherlands
Elsevier B.V
01-04-2021
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | •Acute myeloid leukemia remains the most lethal of leukemias.•Leukemic stem cells are associated with disease relapses.•Cell signaling pathways are targets to eliminate AML stem cells.
Acute myeloid leukemia (AML) remains the most lethal of leukemias and a small population of cells called leukemic stem cells (LSCs) has been associated with disease relapses. Some cell signaling pathways play an important role in AML survival, proliferation and self-renewal properties and are abnormally activated or suppressed in LSCs. This includes the NF-κB, Wnt/β-catenin, Hedgehog, Notch, EGFR, JAK/STAT, PI3K/AKT/mTOR, TGF/SMAD and PPAR pathways. This review aimed to discuss these pathways as molecular targets for eliminating AML LSCs. Herein, inhibitors/activators of these pathways were summarized as a potential new anti-AML therapy capable of eliminating LSCs to guide future researches. The clinical use of cell signaling pathways data can be useful to enhance the anti-AML therapy. |
---|---|
AbstractList | Acute myeloid leukemia (AML) remains the most lethal of leukemias and a small population of cells called leukemic stem cells (LSCs) has been associated with disease relapses. Some cell signaling pathways play an important role in AML survival, proliferation and self-renewal properties and are abnormally activated or suppressed in LSCs. This includes the NF-κB, Wnt/β-catenin, Hedgehog, Notch, EGFR, JAK/STAT, PI3K/AKT/mTOR, TGF/SMAD and PPAR pathways. This review aimed to discuss these pathways as molecular targets for eliminating AML LSCs. Herein, inhibitors/activators of these pathways were summarized as a potential new anti-AML therapy capable of eliminating LSCs to guide future researches. The clinical use of cell signaling pathways data can be useful to enhance the anti-AML therapy. •Acute myeloid leukemia remains the most lethal of leukemias.•Leukemic stem cells are associated with disease relapses.•Cell signaling pathways are targets to eliminate AML stem cells. Acute myeloid leukemia (AML) remains the most lethal of leukemias and a small population of cells called leukemic stem cells (LSCs) has been associated with disease relapses. Some cell signaling pathways play an important role in AML survival, proliferation and self-renewal properties and are abnormally activated or suppressed in LSCs. This includes the NF-κB, Wnt/β-catenin, Hedgehog, Notch, EGFR, JAK/STAT, PI3K/AKT/mTOR, TGF/SMAD and PPAR pathways. This review aimed to discuss these pathways as molecular targets for eliminating AML LSCs. Herein, inhibitors/activators of these pathways were summarized as a potential new anti-AML therapy capable of eliminating LSCs to guide future researches. The clinical use of cell signaling pathways data can be useful to enhance the anti-AML therapy. |
ArticleNumber | 103277 |
Author | Costa, Rafaela G.A. Bezerra, Daniel P. Dias, Ingrid R.S.B. Dias, Rosane B. Silva, Suellen L.R. Rodrigues, Ana Carolina B. da C. |
Author_xml | – sequence: 1 givenname: Ana Carolina B. da C. surname: Rodrigues fullname: Rodrigues, Ana Carolina B. da C. – sequence: 2 givenname: Rafaela G.A. surname: Costa fullname: Costa, Rafaela G.A. – sequence: 3 givenname: Suellen L.R. surname: Silva fullname: Silva, Suellen L.R. – sequence: 4 givenname: Ingrid R.S.B. surname: Dias fullname: Dias, Ingrid R.S.B. – sequence: 5 givenname: Rosane B. surname: Dias fullname: Dias, Rosane B. – sequence: 6 givenname: Daniel P. orcidid: 0000-0002-6774-2063 surname: Bezerra fullname: Bezerra, Daniel P. email: daniel.bezerra@fiocruz.br |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/33716201$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkE1PAyEQhonR2A_9C4ajl62wUGCPtVFrUuNFz4SF2UqzHxVoTf-927Tq0cvMZPLOvDPPCJ23XQsIYUomlFBxt57Y4FOAXdfaSU5y2rdZLuUZGlIli4xwQc_7mnCSKZ6rARrFuCaEcC7kJRowJqnICR2ixRzqGke_ak3t2xXemPTxZfYRm4ibrga7rU3AyYQVpIhTh6H2jW9NAjx7WeKYoMG2XxGv0EVl6gjXpzxG748Pb_NFtnx9ep7PlpllkqesNIySKTNKFJwwOq2cIA4sMFDCQuFY31WlNELm1oncsYrJQyhoCVxRx8bo9rh3E7rPLcSkGx8PF5gWum3U-ZRQrhgtZC9VR6kNXYwBKr0JvjFhrynRB456rf846gNHfeTYj96cXLZlA-538AdcL7g_CqD_dech6Gg9tBacD2CTdp3_3-Ubt4mKmQ |
CitedBy_id | crossref_primary_10_1080_10428194_2023_2207698 crossref_primary_10_1002_kjm2_12801 crossref_primary_10_1016_j_biopha_2024_117059 crossref_primary_10_1186_s12859_022_04936_z crossref_primary_10_3389_fnut_2022_1056648 crossref_primary_10_1007_s11033_021_07073_7 crossref_primary_10_1038_s41420_024_01967_8 crossref_primary_10_1016_j_bbrc_2022_06_054 crossref_primary_10_1038_s41467_024_45737_7 crossref_primary_10_1111_jcmm_18333 crossref_primary_10_1002_cac2_12235 crossref_primary_10_1016_j_ijbiomac_2022_03_057 crossref_primary_10_1080_14737140_2022_2093720 crossref_primary_10_1038_s41420_024_01909_4 crossref_primary_10_1038_s41540_024_00352_6 crossref_primary_10_1186_s12943_024_02013_y crossref_primary_10_1007_s00705_023_05780_z crossref_primary_10_1007_s11033_024_09452_2 crossref_primary_10_1007_s10142_023_00980_x crossref_primary_10_3389_fphar_2022_864714 crossref_primary_10_1016_j_bcp_2023_115539 crossref_primary_10_1016_j_redox_2023_102692 |
Cites_doi | 10.1182/blood-2011-07-365890 10.1038/leu.2014.340 10.1158/1541-7786.MCR-14-0363 10.1111/j.1365-2141.1976.tb03563.x 10.1097/01.mco.0000134360.30911.bb 10.1016/S0006-2952(00)00391-9 10.1016/j.semcancer.2019.01.001 10.1172/JCI88894 10.1158/1078-0432.CCR-16-1904 10.7326/0003-4819-103-4-620 10.1016/j.ccell.2015.12.011 10.1038/s41591-020-0910-8 10.1093/jnci/djt440 10.1016/S2352-3026(15)00096-4 10.1023/A:1011342220621 10.1371/journal.pone.0096698 10.3324/haematol.2018.192062 10.3390/ijms19061738 10.1093/carcin/bgr176 10.1038/nature04870 10.18632/oncotarget.8844 10.1038/onc.2016.86 10.1016/j.exphem.2013.05.287 10.1371/journal.pgen.1002781 10.1016/j.ccr.2009.11.020 10.1111/bjh.12691 10.1016/S0168-9525(99)01916-2 10.18632/oncotarget.3545 10.3390/cells8050482 10.1016/S1097-2765(02)00636-6 10.2174/092986707781368423 10.1111/nyas.14027 10.1182/blood-2009-03-209734 10.1182/blood-2009-03-209262 10.3322/caac.21492 10.1038/nrd2926 10.1182/blood.V97.7.2177 10.1021/jo300888s 10.1097/01.cad.0000173476.67239.3b 10.1074/jbc.M306782200 10.2174/156802612799436669 10.1016/j.bbrc.2015.03.007 10.18632/oncotarget.14220 10.1042/BJ20071427 10.1126/scitranslmed.aaj2025 10.1158/1535-7163.1249.3.10 10.1038/nrm909 10.1038/nature04703 10.1016/j.pharmthera.2013.12.004 10.3324/haematol.2011.054734 10.1038/onc.2008.313 10.1016/j.ccr.2006.08.007 10.1016/j.celrep.2017.12.055 10.1186/s13045-019-0765-y 10.1016/j.exphem.2014.07.071 10.1182/blood-2005-05-1989 10.1046/j.1365-2141.2001.03102.x 10.1073/pnas.0900089106 10.18632/oncotarget.16304 10.1182/blood-2004-11-4468 10.1016/j.ejps.2012.12.003 10.1073/pnas.1212802109 10.1016/j.bbrc.2019.05.091 10.1186/2040-2384-1-8 10.1084/jem.20121527 10.1038/s41388-018-0431-9 10.1038/srep25476 10.18632/oncotarget.2016 10.18632/oncotarget.22248 10.3324/haematol.2009.009811 10.1080/14737140.2019.1652095 10.1074/jbc.M113.511170 10.1186/s12943-018-0793-1 10.1093/molbev/msp075 10.1182/blood.V98.8.2301 10.1016/j.it.2018.08.006 10.1158/0008-5472.CAN-09-3950 10.1038/nature13283 10.1016/j.tibs.2004.03.006 10.1158/1541-7786.MCR-16-0275-T 10.1111/j.1349-7006.2009.01111.x 10.3390/genes7090061 10.1634/stemcells.2005-0303 10.1101/gad.1350705 10.1073/pnas.252462599 10.1126/scitranslmed.aaz8264 10.1002/ijc.28198 10.1182/blood-2013-05-505735 10.1016/j.critrevonc.2015.12.005 10.1016/j.ccr.2004.06.007 10.1016/j.beha.2006.10.005 10.1111/j.1365-2141.1991.tb04444.x 10.18632/oncotarget.10397 10.1387/ijdb.103067cc 10.1016/j.bbagrm.2010.05.004 10.1016/S0092-8674(02)00701-8 10.1038/labinvest.2014.89 10.1016/j.jprot.2011.11.004 10.3390/cancers8020022 10.1038/sigtrans.2016.42 10.1016/j.canlet.2019.07.012 10.3390/cancers7030851 10.1007/s12185-013-1433-6 10.1038/s41375-019-0635-1 10.1186/1756-8722-1-20 10.1002/stem.1631 10.1016/j.ccell.2018.10.005 10.7326/0003-4819-103-3-460 10.1038/nrn704 10.1038/sj.leu.2403653 10.1016/j.molcel.2007.03.003 10.1038/nm1483 10.1016/j.yexcr.2009.05.007 10.1038/ncomms9510 10.1158/1535-7163.MCT-14-0171 10.1126/scitranslmed.3000349 10.1016/j.leukres.2015.05.006 10.1038/onc.2008.245 10.1186/2050-7771-1-5 10.3390/cells7110208 10.1186/s12943-016-0571-x 10.1038/s41375-019-0441-9 10.1158/1078-0432.CCR-12-0284 10.1186/s12967-015-0453-9 10.1016/S0968-0004(00)01624-8 10.4161/org.4.2.5851 10.1002/mc.10084 10.1016/j.bcp.2008.05.024 10.1159/000055271 10.1038/srep15646 10.1182/blood-2010-07-294827 10.1038/leu.2016.209 10.1172/JCI62279 10.1016/j.tibs.2009.01.003 10.1182/blood-2006-01-010199 10.18632/oncotarget.9777 10.1038/sj.leu.2404732 10.1080/13543776.2020.1703952 10.2174/1389557516666160321114917 10.1186/s13045-015-0211-8 10.3390/genes9010024 10.1084/jem.20121484 10.1182/blood.2020005895 10.1016/j.leukres.2013.10.026 10.1016/j.stem.2009.08.018 10.1007/s13277-015-4101-z 10.1038/onc.2010.511 10.1016/j.stem.2012.12.013 10.3389/fonc.2019.00582 10.1038/s41590-019-0518-7 10.1101/gad.1212704 10.1002/ijc.25806 10.1242/jcs.114.24.4359 10.1158/0008-5472.CAN-12-0255 10.1182/blood-2004-10-4135 10.1038/sj.leu.2401903 10.1016/j.pharmthera.2013.02.003 10.1038/leu.2011.385 10.1016/j.leukres.2010.06.024 10.1073/pnas.1302352110 10.3324/haematol.2013.085209 10.1146/annurev.med.53.082901.104018 10.1093/carcin/bgt127 10.1038/nature08734 10.1016/j.ccr.2009.02.011 10.1158/1078-0432.CCR-17-1556 10.17305/bjbms.2018.2756 10.1038/nrc2664 10.1126/scitranslmed.aaa5731 10.1093/annonc/mdi077 10.1038/s41586-019-1835-6 10.1126/science.1106148 10.1111/ejh.12592 10.1016/j.ccell.2020.05.014 10.1038/onc.2008.457 10.1038/nrc1275 10.1111/bjh.15571 10.3389/fgene.2019.00556 10.1038/s41467-020-14590-9 10.3390/cells8020147 10.1182/blood-2009-06-227603 10.1186/gb-2004-5-12-253 10.1038/sj.onc.1203481 10.1002/pro.3122 10.3389/fonc.2019.01358 10.18632/oncotarget.11342 10.1182/blood-2013-02-486142 10.1038/cddis.2017.176 10.1172/JCI41495 10.1186/s13046-019-1295-8 10.1101/gad.1693608 10.1016/j.clml.2019.01.006 10.1016/j.ebiom.2018.11.039 10.1586/era.10.203 10.1016/j.canlet.2015.07.048 10.1097/HS9.0000000000000312 10.1073/pnas.1703057114 10.1016/j.tiv.2006.07.007 10.1038/sj.onc.1209087 10.1016/j.redox.2018.10.006 10.1172/JCI68101 10.1038/s41591-019-0472-9 10.1073/pnas.0704271104 10.1242/dev.120154 10.1182/blood-2010-08-301879 10.1182/bloodadvances.2018026633 10.1182/blood-2015-09-667808 10.1038/labinvest.2014.125 10.1038/onc.2012.469 10.1016/j.tibs.2003.09.003 10.1016/j.stem.2010.11.014 10.1038/leu.2013.68 10.1186/s13045-016-0294-x 10.1158/0008-5472.CAN-11-1982 10.1038/nrg1879 10.18632/oncotarget.7964 10.1007/s00428-005-1264-9 10.1111/cas.13019 10.1126/science.1186624 10.1016/j.stem.2011.02.006 10.1016/j.ccr.2010.10.032 10.1038/sj.cdd.4401000 10.3390/cells8111403 10.1007/s12032-012-0395-5 10.1016/j.stem.2015.08.008 10.1016/S0092-8674(00)81575-5 10.1084/jem.20130990 10.1182/blood-2006-08-039073 10.18632/oncotarget.114 10.1038/cr.2010.177 10.3324/haematol.2014.112748 10.1002/1878-0261.12155 10.1182/blood-2002-11-3429 10.1038/nm.2882 10.1101/gad.184341.111 10.2174/138945010790031063 10.1182/blood-2007-03-083048 10.1158/1535-7163.MCT-13-0963 10.1038/367645a0 10.2217/fon.11.25 10.1593/neo.121480 10.1182/blood-2015-08-604520 10.1159/000443075 10.3324/haematol.2018.205534 10.1158/1078-0432.CCR-17-2824 10.1016/j.jsps.2013.12.009 10.4252/wjsc.v10.i4.34 10.1182/blood-2014-01-551234 10.1002/ijc.24748 10.3390/cancers11121958 10.1016/j.cellsig.2009.01.004 10.1172/JCI120156 10.1016/S0092-8674(02)00808-5 10.18632/oncotarget.7772 10.1158/0008-5472.CAN-09-1962 10.1038/leu.2008.144 10.1002/cmdc.201700703 10.1182/blood-2007-05-090621 10.1038/nature05933 |
ContentType | Journal Article |
Copyright | 2021 Elsevier B.V. Copyright © 2021 Elsevier B.V. All rights reserved. |
Copyright_xml | – notice: 2021 Elsevier B.V. – notice: Copyright © 2021 Elsevier B.V. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
DOI | 10.1016/j.critrevonc.2021.103277 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0461 |
EndPage | 103277 |
ExternalDocumentID | 10_1016_j_critrevonc_2021_103277 33716201 S1040842821000652 |
Genre | Journal Article Review |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29F 4.4 457 4CK 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXUO ABBQC ABFNM ABJNI ABLJU ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFS ACIUM ACRLP ADEZE ADMUD AEBSH AEKER AENEX AEVXI AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX AXJTR BKOJK BLXMC BNPGV CS3 DU5 EBS EFJIC EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W KOM LCYCR M29 M41 MO0 N9A O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SEL SES SEW SSH SSZ T5K UDS W2D WUQ Z5R ~G- AAXKI AFJKZ AKRWK CGR CUY CVF ECM EIF NPM AAYXX CITATION 7X8 |
ID | FETCH-LOGICAL-c374t-ba31053a86940315fd60dece3e86ce9d34038b7a672cd62d3f37d3f391be481d3 |
ISSN | 1040-8428 |
IngestDate | Fri Oct 25 23:56:53 EDT 2024 Thu Sep 26 18:42:38 EDT 2024 Sat Sep 28 08:27:58 EDT 2024 Fri Feb 23 02:45:25 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | LTC-IC IRS1 RANK IL-1R [PtdIns (3,4,5)P3] (PIP3) AP-1 PLZF TNF Frz PI3K PPAR GSK3 IGFR-1 PPRE R-SMAD CK1α VPS34 MUC1-C IL TKIs GMP Ara-C RUNX1 BCR BAFFR LPA PDK-1 DMAPT ERK DNMT1 FDA BM LTβR β-TRCP SCID Cell signaling GPCRs Leukemic stem cells PDGFR miRNA Wnt BMP TNFSF13 IKK STAT LSCs TBL1 RHEB ITD ATM ETO FLT3 JNK TGFs PTEN MLL NF-κB PYGO mTOR RARa VEGFR AMH MDS AML NOD HSP TSC DNMT3A IGF-1 GDFs TYK2 I-SMADs TCF ROS PCP PI-103 Acute myeloid leukemia [PtdIns (4,5)P2] (PIP2) TCR Target therapy A-PACs XIAP RXR Raptor Co-SMAD TLR IFNs CEBPa TNFR PDX VEGF siRNA LEF TSGs LICs PML NIK APC JAK PH HSCs DVL |
Language | English |
License | Copyright © 2021 Elsevier B.V. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c374t-ba31053a86940315fd60dece3e86ce9d34038b7a672cd62d3f37d3f391be481d3 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1 |
ORCID | 0000-0002-6774-2063 |
PMID | 33716201 |
PQID | 2501483197 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | proquest_miscellaneous_2501483197 crossref_primary_10_1016_j_critrevonc_2021_103277 pubmed_primary_33716201 elsevier_sciencedirect_doi_10_1016_j_critrevonc_2021_103277 |
PublicationCentury | 2000 |
PublicationDate | April 2021 2021-Apr 2021-04-00 20210401 |
PublicationDateYYYYMMDD | 2021-04-01 |
PublicationDate_xml | – month: 04 year: 2021 text: April 2021 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Critical reviews in oncology/hematology |
PublicationTitleAlternate | Crit Rev Oncol Hematol |
PublicationYear | 2021 |
Publisher | Elsevier B.V |
Publisher_xml | – name: Elsevier B.V |
References | Kikushige, Shima, Takayanagi (bib0625) 2010; 7 Schwarz, Romanski, Puccetti, Wietbrauk, Vogel, Keller, Scott, Serve, Bug (bib1045) 2011; 35 Hong, Yang, Kim, Shim, Lee, Lee, Park, Nam, Ryoo, Oh (bib0495) 2014; 32 Lobry, Ntziachristos, Ndiaye-Lobry, Oh, Cimmino, Zhu, Araldi, Hu, Freund, Abdel-Wahab, Ibrahim, Skokos, Armstrong, Levine, Park, Aifantis (bib0745) 2013; 210 Chapuis, Egan, Bar (bib0205) 2019; 25 Chung, Park, Kang, Kim, Eaves, Oh (bib0225) 2006; 108 Beghini, Corlazzoli, Del Giacco, Re, Lazzaroni, Brioschi, Valentini, Ferrazzi, Ghilardi, Righi, Turrini, Mignardi, Cesana, Bronte, Nilsson, Morra, Cairoli (bib0065) 2012; 14 Jones, Stevens, D’Alessandro (bib0585) 2018; 34 Krishna, Jana, Singhal, Horne, Awasthi, Salgia, Singhal (bib0660) 2019; 461 Komiya, Habas (bib0650) 2008; 4 Mahmud, Kornblau, Ter Elst, Scherpen, Qiu, Coombes, de Bont (bib0770) 2016; 9 Levy, Darnell (bib0710) 2002; 3 Grandage, Gale, Linch, Khwaja (bib0385) 2005; 19 Braun, Carvalho, Coquelle (bib0130) 2006; 107 Ikezoe, Miller, Kawano (bib0525) 2001; 61 Kim, Sarbassov, Ali, King, Latek, Erdjument-Bromage, Tempst, Sabatini (bib0630) 2002; 110 Duchartre, Kim, Kahn (bib0290) 2016; 99 Jiang, Mu, Wang, Ye, Si, Ning, Li, Li (bib0565) 2014; 9 Fiskus, Sharma, Saha, Shah, Devaraj, Sun, Horrigan, Leveque, Zu, Iyer, Bhalla (bib0330) 2015; 29 Xu, Wang, Li, Chen, He, Deng, Kannappan, Zha, Dong, Wang (bib1265) 2017; 8 Chapellier, Peña-Martínez, Ramakrishnan, Eriksson, Talkhoncheh, Orsmark-Pietras, Lilljebjörn, Högberg, Hagström-Andersson, Fioretos, Larsson, Järås (bib0200) 2019; 104 Liu, Yu, Zhao, Qin, Chu, Wu (bib0740) 2018; 17 Rimkus, Carpenter, Qasem, Chan, Lo (bib0965) 2016; 8 Xu, Simpson, Scialla, Bagg, Carroll (bib1255) 2003; 102 Kagoya, Yoshimi, Kataoka, Nakagawa, Kumano, Arai, Kobayashi, Saito, Iwakura, Kurokawa (bib0600) 2014; 124 Lim, Gondek, Li, Wang, Ma, Chang, Huso, Foerster, Marchionni, McGovern, Watkins, Peacock, Levis, Smith, Merchant, Small, Matsui (bib0725) 2015; 7 Xu, Thompson, Carroll (bib1260) 2005; 106 Li, Chen, Zhu, Ding, Zhong, Huang, Jiang, Wang, Yin, Zhu, Li, Meng (bib0715) 2016; 7 Polivka, Janku (bib0935) 2014; 142 Cheng, Zhang, Alexander, Yao, MacLennan, Pan, Huang, Wang, Montironi, Lopez-Beltran (bib0220) 2011; 7 Han, Jorgensen, Brooks (bib0460) 2017; 23 Chung, Klimek, Park (bib0230) 2014; 42 Zhou, Chan, Bi, Lu, Chong, Chooi, Cheong, Liu, Ching, Zhou, Osato, Tan, Ng, Ng, Wang, Zeng, Chng (bib1370) 2017; 15 Li, Volk, Zhang, Cannova, Dai, Hao, Hu, Sun, Xu, Wei, Breslin, Nand, Chen, Kini, Zhu, Zhang (bib0720) 2017; 8 Guzman, Neering, Upchurch, Grimes, Howard, Rizzieri, Luger, Jordan (bib0425) 2001; 98 Ma, Yang, Niu, Cheng, Zhong, Zheng, Xiong, Li, Xiang, Chen, Zhou, Wei, Yang (bib0760) 2015; 5 Ikushima, Todo, Ino, Takahashi, Miyazawa, Miyazono (bib0535) 2009; 5 Pires, Silva, Ferreira, Abdelhay (bib0930) 2018; 9 Cetinkalp, Simsir, Sahin, Saydam, Ural, Yilmaz (bib0185) 2015; 23 Ghadiany, Tabarraee, Salari (bib0370) 2019; 19 Paz, Levy, Oliveira, de Melo, de Freitas, Reichert, Rodrigues, Pereira, Bydlowski (bib0905) 2019; 8 Deangelo, Neuberg, Amrein, Berchuck, Wadleigh, Sirulnik, Galinsky, Golub, Stegmaier, Stone (bib0260) 2014; 38 Pei, Minhajuddin, Callahan, Balys, Ashton, Neering, Lagadinou, Corbett, Ye, Liesveld, O’Dwyer, Li, Shi, Greninger, Settleman, Benes, Hagen, Munger, Crooks, Becker, Jordan (bib0910) 2013; 288 Skoda, Simovic, Karin, Kardum, Vranic, Serman (bib1090) 2018; 18 Bai, Ueno, Vogt (bib0050) 2009; 125 Zeng, Wang, Qiu, Mak, Coombes, Yoo, Zhang, Jessen, Liu, Rommel, Fruman, Kantarjian, Kornblau, Andreeff, Konopleva (bib1330) 2016; 7 Ni, Ergin, Huang (bib0865) 2001; 115 Lagadinou, Sach, Callahan, Rossi, Neering, Minhajuddin (bib0675) 2013; 12 Tagde, Rajabi, Stroopinsky, Gali, Alam, Bouillez, Kharbanda, Stone, Avigan, Kufe (bib1120) 2016; 7 Bystrom, Bezerra, Hsu, Zong, Lara-Martínez, De Leon, Emmanuel, Méry, Gardenghi, Hassane, Neto, Cunningham-Rundles, Becker, Rivella, Guzman (bib0150) 2019; 3 Weber, Schreiber, Daub (bib1235) 2012; 75 Park, Chapuis, Bardet, Tamburini, Gallay, Willems, Knight, Shokat, Azar, Viguié, Ifrah, Dreyfus, Mayeux, Lacombe, Bouscary (bib0895) 2008; 22 Tontonoz, Nagy, Alvarez, Thomazy, Evans (bib1165) 1998; 93 Farooqi, de la Roche, Djamgoz, Siddik (bib0315) 2019; 58 Hong, Xiao, Yang, Han, Cao, Li, Wu, Gong, Zhou, Xu, Meng, Ma, Zhou (bib0490) 2011; 32 Chae, Bothwell (bib0195) 2018; 39 Tabe, Konopleva, Andreeff, Ohsaka (bib1115) 2012; 483656 Dubois, Eeckhoute, Lefebvre (bib0285) 2017; 127 Takada, Makishima (bib1125) 2020; 30 Han, Zhang, Dail (bib0465) 2020; 105 Hirase, Yanase, Mu (bib0485) 1999; 57 Hosen, Park, Tatsumi (bib0510) 2007; 104 Nahlé (bib0855) 2004; 7 Han, Gupta, Prasad, Aggarwal (bib0455) 2014; 13 Tran, Zheng (bib1170) 2017; 26 Boyd, Salci, Shapovalova, McIntyre, Bhatia (bib0125) 2013; 41 Sari, Phi, Jun, Wijaya, Lee, Kwon (bib1020) 2018; 7 Piazza, Manni, Ruzzene, Pinna, Gurrieri, Semenzato (bib0920) 2012; 26 Viennois, Xiao, Ayyadurai, Wang, Wang, Zhang, Chen, Merlin (bib1210) 2014; 94 Stein, Baldwin (bib1100) 2013; 121 Gama-Norton, Ferrando, Ruiz-Herguido, Liu, Guiu, Islam, Maeda (bib0355) 2015; 6 Wang, Liu, Malek, Zheng, Liu (bib1225) 2011; 8 Garg, Shanmukhaiah, Marathe, Mishra, Babu Rao, Ghosh, Madkaikar (bib0360) 2016; 96 Heuser, Sly, Argiropoulos, Kuchenbauer, Lai, Weng, Leung, Lin, Brookes, Fung, Valk, Delwel, Löwenberg, Krystal, Humphries (bib0480) 2009; 114 Zhang, Kang, Lu, Zhang, Wu, Wu, Zheng, Tuladhar, Shi, Wang, Morlock, Yao, Huang, Maire, Kim, Williams, Xu, Chen, Zhang, Lum (bib1350) 2019; 39 Schumich, Prchal-Murphy, Maurer-Granofszky, Hoelbl-Kovacic, Mühlegger, Pötschger, Fajmann, Haas, Nebral, von Neuhoff, Zimmermann, Boztug, Rasche, Dolezal, Walter, Reinhardt, Sexl, Dworzak (bib1040) 2020; 4 Bardet, Tamburini, Ifrah, Dreyfus, Mayeux, Bouscary, Lacombe (bib0060) 2006; 91 Guo, Wang, Zhang, Levit, Gao, Barberis, Tabart, Zhang, Hoffmann, Wiederschain, Rocnik, Sun, Murtie, Lengauer, Gross, Zhang, Cheng, Patel, Schio, Adrian, Huang (bib0415) 2014; 124 Ji, Ding, Sun, Zhang, Gao, Song, Yang, Liu, Zhang, Li, Gao (bib0560) 2016; 7 Shastri, Choudhary, Teixeira, Gordon-Mitchell, Ramachandra, Bernard, Bhattacharyya, Lopez, Pradhan, Giricz, Ravipati, Wong, Cole, Bhagat, Feld, Dhar, Bartenstein, Thiruthuvanathan, Wickrema, Ye, Verma (bib1055) 2018; 128 Sarbassov, Guertin, Ali, Sabatini (bib1015) 2005; 307 Jaffe, Harris, Stein (bib0555) 2001 Borah, Kumar (bib0115) 2019 Zhou, Chooi, Ching, Quah, Toh, Ng, Tan, Chng (bib1375) 2018; 10 Dombret, Gardin (bib0280) 2016; 127 Yu, Shin, Lee, Lee (bib1305) 2014; 94 Espinoza, Miele (bib0305) 2013; 139 Rory, Jan, Prajwal, Amer (bib0980) 2019; 19 Tubi, Nunes, Brancalion, Breatta, Manni, Mandato, Zaffino, Macaccaro, Carrino, Gianesin, Trentin, Binotto, Zambello, Semenzato, Gurrieri, Piazza (bib1185) 2017; 31 Shallis, Bewersdorf, Boddu, Zeidan (bib1050) 2019; 19 Shimada, Nakamura, Ishida, Kishi, Yonehara, Konishi (bib1070) 2002; 35 Kannan, Sutphin, Hall, Golfman, Fang, Nolo, Akers, Hammitt, McMurray, Kornblau, Melnick, Figueroa, Zweidler-McKay (bib0605) 2013; 210 Ghosh, Tergaonkar, Rothlin, Correa, Bottero, Bist, Verma, Hunter (bib0375) 2006; 10 Lau, Huh, Madero-Marroquin (bib0695) 2019; 38 Takeuchi, Nishioka, Ikezoe, Yang, Yokoyama (bib1140) 2015; 39 Martelli, Evangelisti, Chiarini, McCubrey (bib0800) 2010; 1 Vardiman, Thiele, Arber, Brunning, Borowitz, Porwit, Harris, Le Beau, Hellström-Lindberg, Tefferi, Bloomfield (bib1200) 2009; 114 Chung, Eng, Hu (bib0235) 2017; 9 Karin (bib0615) 2006; 441 Chen (bib0210) 2012; 72 Gruszka, Valli, Alcalay (bib0405) 2019; 8 Rizo, Olthof, Han, Vellenga, de Haan, Schuringa (bib0970) 2009; 114 Cochrane, Szczepny, Watkins, Cain (bib0240) 2015; 7 Engelman (bib0295) 2009; 9 Radpour, Riether, Simillion, Höpner, Bruggmann, Ochsenbein (bib0955) 2019; 33 Gal, Amariglio, Trakhtenbrot (bib0350) 2006; 20 Molckovsky, Siu (bib0835) 2008; 1 Helsmoortel, Bresolin, Lammens, Cavé, Noellke, Caye, Ghazavi, de Vries, Hasle, Labarque, Masetti, Stary, van den Heuvel-Eibrink, Philippé, Van Roy, Benoit, Speleman, Niemeyer, Flotho, Basso (bib0475) 2016; 127 Altaba, Palma, Dahmane (bib0025) 2002; 3 Moreno-Martínez, Nomdedeu, Lara-Castillo, Etxabe, Pratcorona, Tesi, Díaz-Beyá, Rozman, Montserrat, Urbano-Ispizua, Esteve, Risueño (bib0840) 2014; 5 Theodosiou, Arhondakis, Baumann, Kossida (bib1155) 2009; 26 Zahreddine, Culjkovic-Kraljacic, Assouline, Gendron, Romeo, Morris, Cormack, Jaquith, Cerchietti, Cocolakis, Amri, Bergeron, Leber, Becker, Pei, Jordan, Miller, Borden (bib1320) 2014; 511 Siveen, Uddin, Mohammad (bib1085) 2017; 16 Antfolk, Sjöqvist, Cheng, Isoniemi, Duran, Rivero-Muller, Antila, Niemi, Landor, Bouten, Bayless, Eriksson, Sahlgren (bib0035) 2017; 114 Tsao, Kornblau, Safe (bib1180) 2010; 70 Grosjean-Raillard, Tailler, Adès (bib0400) 2009; 28 Liu, Huang, Lin (bib0730) 2005; 16 Manning, Cantley (bib0790) 2003; 28 Weiss, Attisano (bib1240) 2013; 2 Latuske, Stamm, Klokow, Vohwinkel, Muschhammer, Bokemeyer, Jucker, Kebenko, Fiedler, Wellbrock (bib0690) 2017; 8 Martelli, Tazzari, Evangelisti, Chiarini, Blalock, Billi, Manzoli, McCubrey, Cocco (bib0795) 2007; 14 Bezerra, Pessoa, de Moraes, Saker-Neto, Silveira, Costa-Lotufo (bib0100) 2013; 48 Capaccione, Pine (bib0160) 2013; 34 Sarry, Murphy, Perry, Sanchez, Secreto, Keefer, Swider, Strzelecki, Cavelier, Récher, Mansat-De Mas, Delabesse, Danet-Desnoyers, Carroll (bib1025) 2011; 121 Salik, Yi, Hassan, Santiappillai, Vick, Connerty, Duly, Trahair, Woo, Beck, Liu, Spiekermann, Jeremias, Wang, Kavallaris, Haber, Norris, Liebermann, D’Andrea, Murriel, Wang (bib1000) 2020 Bezerra, Militão, Castro, Pessoa, Moraes, Silveira (bib0095) 2007; 21 Saito, Kitamura, Hijikata (bib0995) 2010; 2 Zhang, Fang, Wang (bib1345) 2014; 1 Ikezoe, Yang, Nishioka, Kojima, Takeuchi, Phillip Koeffler, Yokoyama (bib0530) 2011; 128 Niewiadomski, Niedziółka, Markiewicz, Uśpieński, Baran, Chojnowska (bib0870) 2019; 8 Chadwick, Nostro, Baron, Mottram, Brady, Buckle (bib0190) 2007; 25 Bennett, Catovsky, Daniel, Flandrin, Galton, Gralnick, Sultan (bib0070) 1976; 33 Lainey, Wolfromm, Marie, Enot, Scoazec, Bouteloup, Leroy, Micol, De Botton, Galluzzi, Fenau Lechman (10.1016/j.critrevonc.2021.103277_bib0700) 2016; 29 Grandage (10.1016/j.critrevonc.2021.103277_bib0385) 2005; 19 Sari (10.1016/j.critrevonc.2021.103277_bib1020) 2018; 7 Xu (10.1016/j.critrevonc.2021.103277_bib1260) 2005; 106 Xiu (10.1016/j.critrevonc.2021.103277_bib1250) 2018; 22 Bardet (10.1016/j.critrevonc.2021.103277_bib0060) 2006; 91 Liu (10.1016/j.critrevonc.2021.103277_bib0735) 2009; 8 Swerdlow (10.1016/j.critrevonc.2021.103277_bib1110) 2008 Moustakas (10.1016/j.critrevonc.2021.103277_bib0850) 2001; 114 Yilmaz (10.1016/j.critrevonc.2021.103277_bib1295) 2006; 441 Helsmoortel (10.1016/j.critrevonc.2021.103277_bib0475) 2016; 127 Jones (10.1016/j.critrevonc.2021.103277_bib0585) 2018; 34 Kaowinn (10.1016/j.critrevonc.2021.103277_bib0610) 2019; 514 Jin (10.1016/j.critrevonc.2021.103277_bib0575) 2006; 12 Mandato (10.1016/j.critrevonc.2021.103277_bib0785) 2016; 35 Sigismund (10.1016/j.critrevonc.2021.103277_bib1075) 2018; 12 Trowbridge (10.1016/j.critrevonc.2021.103277_bib1175) 2012; 26 van Rhenen (10.1016/j.critrevonc.2021.103277_bib1195) 2007; 110 Vardiman (10.1016/j.critrevonc.2021.103277_bib1200) 2009; 114 Chung (10.1016/j.critrevonc.2021.103277_bib0230) 2014; 42 Backer (10.1016/j.critrevonc.2021.103277_bib0040) 2008; 410 Tan (10.1016/j.critrevonc.2021.103277_bib1150) 2019; 38 Ghosh (10.1016/j.critrevonc.2021.103277_bib0380) 2019; 1443 Tibes (10.1016/j.critrevonc.2021.103277_bib1160) 2015; 8 Lim (10.1016/j.critrevonc.2021.103277_bib0725) 2015; 7 Bixby (10.1016/j.critrevonc.2021.103277_bib0105) 2019; 185 Bezerra (10.1016/j.critrevonc.2021.103277_bib0100) 2013; 48 Ropio (10.1016/j.critrevonc.2021.103277_bib0975) 2016; 7 Xu (10.1016/j.critrevonc.2021.103277_bib1265) 2017; 8 Zhou (10.1016/j.critrevonc.2021.103277_bib1365) 2015; 6 Chae (10.1016/j.critrevonc.2021.103277_bib0195) 2018; 39 Guzman (10.1016/j.critrevonc.2021.103277_bib0430) 2001; 97 Patterson (10.1016/j.critrevonc.2021.103277_bib0900) 2000; 16 Savona (10.1016/j.critrevonc.2021.103277_bib1030) 2018; 24 Long (10.1016/j.critrevonc.2021.103277_bib0755) 2016; 38 O’Hear (10.1016/j.critrevonc.2021.103277_bib0875) 2015; 100 Saito (10.1016/j.critrevonc.2021.103277_bib0995) 2010; 2 Viennois (10.1016/j.critrevonc.2021.103277_bib1210) 2014; 94 Naka (10.1016/j.critrevonc.2021.103277_bib0860) 2010; 463 Decker (10.1016/j.critrevonc.2021.103277_bib0265) 2000; 19 Ikezoe (10.1016/j.critrevonc.2021.103277_bib0530) 2011; 128 Moreno-Martínez (10.1016/j.critrevonc.2021.103277_bib0840) 2014; 5 Pollyea (10.1016/j.critrevonc.2021.103277_bib0940) 2014; 99 Rimkus (10.1016/j.critrevonc.2021.103277_bib0965) 2016; 8 Ito (10.1016/j.critrevonc.2021.103277_bib0545) 2012; 18 Weber (10.1016/j.critrevonc.2021.103277_bib1235) 2012; 75 Yang (10.1016/j.critrevonc.2021.103277_bib1280) 2013; 133 Guzman (10.1016/j.critrevonc.2021.103277_bib0425) 2001; 98 Morgensztern (10.1016/j.critrevonc.2021.103277_bib0845) 2005; 16 Capaccione (10.1016/j.critrevonc.2021.103277_bib0155) 2013; 34 Dubois (10.1016/j.critrevonc.2021.103277_bib0285) 2017; 127 Feder (10.1016/j.critrevonc.2021.103277_bib0320) 2020; 34 Tagde (10.1016/j.critrevonc.2021.103277_bib1120) 2016; 7 Ali (10.1016/j.critrevonc.2021.103277_bib0020) 2017; 2 Beghini (10.1016/j.critrevonc.2021.103277_bib0065) 2012; 14 Tontonoz (10.1016/j.critrevonc.2021.103277_bib1165) 1998; 93 Takam Kamga (10.1016/j.critrevonc.2021.103277_bib1135) 2019; 11 Grosjean-Raillard (10.1016/j.critrevonc.2021.103277_bib0400) 2009; 28 Ghadiany (10.1016/j.critrevonc.2021.103277_bib0370) 2019; 19 Martinelli (10.1016/j.critrevonc.2021.103277_bib0805) 2015; 2 Deangelo (10.1016/j.critrevonc.2021.103277_bib0260) 2014; 38 Martelli (10.1016/j.critrevonc.2021.103277_bib0795) 2007; 14 Nahlé (10.1016/j.critrevonc.2021.103277_bib0855) 2004; 7 Bae (10.1016/j.critrevonc.2021.103277_bib0045) 2003; 278 Yamaoka (10.1016/j.critrevonc.2021.103277_bib1275) 2004; 5 Yeung (10.1016/j.critrevonc.2021.103277_bib1290) 2010; 18 Bennett (10.1016/j.critrevonc.2021.103277_bib0080) 1985; 103 Lagadinou (10.1016/j.critrevonc.2021.103277_bib0675) 2013; 12 Iwasaki (10.1016/j.critrevonc.2021.103277_bib0550) 2015; 17 Konopleva (10.1016/j.critrevonc.2021.103277_bib0655) 2004; 3 Riether (10.1016/j.critrevonc.2021.103277_bib0960) 2020 Radpour (10.1016/j.critrevonc.2021.103277_bib0955) 2019; 33 Fukushima (10.1016/j.critrevonc.2021.103277_bib0340) 2016; 107 Wu (10.1016/j.critrevonc.2021.103277_bib1245) 2001; 6 Shimada (10.1016/j.critrevonc.2021.103277_bib1070) 2002; 35 Ni (10.1016/j.critrevonc.2021.103277_bib0865) 2001; 115 Siveen (10.1016/j.critrevonc.2021.103277_bib1085) 2017; 16 Ji (10.1016/j.critrevonc.2021.103277_bib0560) 2016; 7 Zeng (10.1016/j.critrevonc.2021.103277_bib1330) 2016; 7 Liu (10.1016/j.critrevonc.2021.103277_bib0730) 2005; 16 Jin (10.1016/j.critrevonc.2021.103277_bib0580) 2010; 70 Loewith (10.1016/j.critrevonc.2021.103277_bib0750) 2002; 10 Yu (10.1016/j.critrevonc.2021.103277_bib1305) 2014; 94 Jordan (10.1016/j.critrevonc.2021.103277_bib0590) 2007; 20 Lau (10.1016/j.critrevonc.2021.103277_bib0695) 2019; 38 American Cancer Society (10.1016/j.critrevonc.2021.103277_bib0030) 2020 Bennett (10.1016/j.critrevonc.2021.103277_bib0075) 1985; 103 Shallis (10.1016/j.critrevonc.2021.103277_bib1050) 2019; 19 Menendez-Gutierrez (10.1016/j.critrevonc.2021.103277_bib0820) 2012; 12 Baliza (10.1016/j.critrevonc.2021.103277_bib0055) 2019; 9 Zhou (10.1016/j.critrevonc.2021.103277_bib1360) 2011; 118 Kume (10.1016/j.critrevonc.2021.103277_bib0670) 2009; 1 Krishna (10.1016/j.critrevonc.2021.103277_bib0660) 2019; 461 Liu (10.1016/j.critrevonc.2021.103277_bib0740) 2018; 17 Rory (10.1016/j.critrevonc.2021.103277_bib0980) 2019; 19 Mikesch (10.1016/j.critrevonc.2021.103277_bib0825) 2007; 21 Quintás-Cardama (10.1016/j.critrevonc.2021.103277_bib0950) 2013; 19 Ghosh (10.1016/j.critrevonc.2021.103277_bib0375) 2006; 10 Hu (10.1016/j.critrevonc.2021.103277_bib0520) 2015; 459 Garg (10.1016/j.critrevonc.2021.103277_bib0360) 2016; 96 Stein (10.1016/j.critrevonc.2021.103277_bib1100) 2013; 121 Zhang (10.1016/j.critrevonc.2021.103277_bib1340) 2013; 110 Ochsenreither (10.1016/j.critrevonc.2021.103277_bib0885) 2012; 119 Yu (10.1016/j.critrevonc.2021.103277_bib1300) 2004; 4 Greene (10.1016/j.critrevonc.2021.103277_bib0390) 1995; 4 Pei (10.1016/j.critrevonc.2021.103277_bib0910) 2013; 288 Manning (10.1016/j.critrevonc.2021.103277_bib0790) 2003; 28 Bennett (10.1016/j.critrevonc.2021.103277_bib0070) 1976; 33 Chadwick (10.1016/j.critrevonc.2021.103277_bib0190) 2007; 25 Cheng (10.1016/j.critrevonc.2021.103277_bib0220) 2011; 7 Ding (10.1016/j.critrevonc.2021.103277_bib0270) 2013; 30 Oliveira (10.1016/j.critrevonc.2021.103277_bib0890) 2019; 20 Bours (10.1016/j.critrevonc.2021.103277_bib0120) 2000; 60 Yao (10.1016/j.critrevonc.2021.103277_bib1285) 2019; 9 Park (10.1016/j.critrevonc.2021.103277_bib0895) 2008; 22 Tabe (10.1016/j.critrevonc.2021.103277_bib1115) 2012; 483656 Weiss (10.1016/j.critrevonc.2021.103277_bib1240) 2013; 2 Sancak (10.1016/j.critrevonc.2021.103277_bib1005) 2007; 25 Yuan (10.1016/j.critrevonc.2021.103277_bib1310) 2008; 27 Franke (10.1016/j.critrevonc.2021.103277_bib0335) 2008; 27 Bray (10.1016/j.critrevonc.2021.103277_bib0135) 2018; 68 Levy (10.1016/j.critrevonc.2021.103277_bib0710) 2002; 3 Piazza (10.1016/j.critrevonc.2021.103277_bib0920) 2012; 26 Ma (10.1016/j.critrevonc.2021.103277_bib0760) 2015; 5 Han (10.1016/j.critrevonc.2021.103277_bib0460) 2017; 23 Komiya (10.1016/j.critrevonc.2021.103277_bib0650) 2008; 4 Polivka (10.1016/j.critrevonc.2021.103277_bib0935) 2014; 142 Rizo (10.1016/j.critrevonc.2021.103277_bib0970) 2009; 114 Sun (10.1016/j.critrevonc.2021.103277_bib1105) 2011; 21 Gupta (10.1016/j.critrevonc.2021.103277_bib0420) 2010; 1799 Li (10.1016/j.critrevonc.2021.103277_bib0715) 2016; 7 Lainey (10.1016/j.critrevonc.2021.103277_bib0680) 2013; 32 Peñuelas (10.1016/j.critrevonc.2021.103277_bib0915) 2009; 15 Dolcet (10.1016/j.critrevonc.2021.103277_bib0275) 2005; 446 Ikushima (10.1016/j.critrevonc.2021.103277_bib0535) 2009; 5 Gal (10.1016/j.critrevonc.2021.103277_bib0350) 2006; 20 Lapidot (10.1016/j.critrevonc.2021.103277_bib0685) 1994; 367 Hong (10.1016/j.critrevonc.2021.103277_bib0495) 2014; 32 Jiang (10.1016/j.critrevonc.2021.103277_bib0565) 2014; 9 Fang (10.1016/j.critrevonc.2021.103277_bib0310) 2020 Tam (10.1016/j.critrevonc.2021.103277_bib1145) 2013; 73 Schumich (10.1016/j.critrevonc.2021.103277_bib1040) 2020; 4 Hay (10.1016/j.critrevonc.2021.103277_bib0470) 2004; 18 Quere (10.1016/j.critrevonc.2021.103277_bib0945) 2011; 117 Zhang (10.1016/j.critrevonc.2021.103277_bib1345) 2014; 1 Guzman (10.1016/j.critrevonc.2021.103277_bib0440) 2014; 105 Borah (10.1016/j.critrevonc.2021.103277_bib0115) 2019 Jaffe (10.1016/j.critrevonc.2021.103277_bib0555) 2001 Kim (10.1016/j.critrevonc.2021.103277_bib0635) 2011; 2011 Zanotti (10.1016/j.critrevonc.2021.103277_bib1325) 2020 Cate (10.1016/j.critrevonc.2021.103277_bib0175) 2010; 11 Pietrobono (10.1016/j.critrevonc.2021.103277_bib0925) 2019; 10 Kobune (10.1016/j.critrevonc.2021.103277_bib0640) 2009; 100 Latuske (10.1016/j.critrevonc.2021.103277_bib0690) 2017; 8 Lobry (10.1016/j.critrevonc.2021.103277_bib0745) 2013; 210 Hoshii (10.1016/j.critrevonc.2021.103277_bib0515) 2012; 122 Irvine (10.1016/j.critrevonc.2021.103277_bib0540) 2016; 6 Hirase (10.1016/j.critrevonc.2021.103277_bib0485) 1999; 57 Hosen (10.1016/j.critrevonc.2021.103277_bib0510) 2007; 104 Santamaria-Martínez (10.1016/j.critrevonc.2021.103277_bib1010) 2009; 315 Karin (10.1016/j.critrevonc.2021.103277_bib0615) 2006; 441 Saiki (10.1016/j.critrevonc.2021.103277_bib0990) 2006; 29 Massagué (10.1016/j.critrevonc.2021.103277_bib0810) 2005; 19 Gu (10.1016/j.critrevonc.2021.103277_bib0410) 2016; 7 Han (10.1016/j.critrevonc.2021.103277_bib0465) 2020; 105 Bezerra (10.1016/j.critrevonc.2021.103277_bib0095) 2007; 21 Altaba (10.1016/j.critrevonc.2021.103277_bib0025) 2002; 3 Brunmeir (10.1016/j.critrevonc.2021.103277_bib0145) 2018; 19 Grieselhuber (10.1016/j.critrevonc.2021.103277_bib0395) 2013; 27 Duchartre (10.1016/j.critrevonc.2021.103277_bib0290) 2016; 99 Varjosalo (10.1016/j.critrevonc.2021.103277_bib1205) 2008; 22 Furqan (10.1016/j.critrevonc.2021.103277_bib0345) 2013; 1 Kagoya (10.1016/j.cri |
References_xml | – volume: 4 start-page: 97 year: 2004 end-page: 105 ident: bib1300 article-title: The STATs of cancer--new molecular targets come of age publication-title: Nat. Rev. Cancer contributor: fullname: Jove – volume: 10 start-page: 34 year: 2018 end-page: 42 ident: bib1375 article-title: NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B publication-title: World J. Stem Cells contributor: fullname: Chng – volume: 13 start-page: 209 year: 2018 end-page: 219 ident: bib0255 article-title: The anticancer potential of peroxisome proliferator-activated receptor antagonists publication-title: Chem Med Chem contributor: fullname: Veschi – volume: 4 start-page: 281 year: 1995 end-page: 299 ident: bib0390 article-title: Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping publication-title: Gene Expr. contributor: fullname: McBride – volume: 8 start-page: 399 year: 2011 end-page: 411 ident: bib1225 article-title: Targeting HIF1α eliminates cancer stem cells in hematological malignancies publication-title: Cell Stem Cell contributor: fullname: Liu – volume: 24 start-page: 7493 year: 2005 end-page: 7501 ident: bib0665 article-title: AKT crystal structure and AKT-specific inhibitors publication-title: Oncogene contributor: fullname: Madison – volume: 7 start-page: 65012 year: 2016 end-page: 65023 ident: bib0560 article-title: Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells publication-title: Oncotarget contributor: fullname: Gao – volume: 514 start-page: 1278 year: 2019 end-page: 1284 ident: bib0610 article-title: Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Chung – volume: 278 start-page: 49530 year: 2003 end-page: 49536 ident: bib0045 article-title: Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B publication-title: J. Biol. Chem. contributor: fullname: Birnbaum – volume: 5 start-page: 15646 year: 2015 ident: bib0760 article-title: SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML publication-title: Sci. Rep. contributor: fullname: Yang – volume: 108 start-page: 1208 year: 2006 end-page: 1215 ident: bib0225 article-title: Unique effects of Stat3 on the early phase of hematopoietic stem cell regeneration publication-title: Blood contributor: fullname: Oh – volume: 17 start-page: 53 year: 2018 ident: bib0740 article-title: EGFR-TKIs resistance via EGFR-independent signaling pathways publication-title: Mol. Cancer contributor: fullname: Wu – volume: 25 start-page: 496 year: 2000 end-page: 502 ident: bib0505 article-title: STAT proteins and transcriptional responses to extracellular signals publication-title: Trends Biochem. Sci. contributor: fullname: Horvath – volume: 8 start-page: 29187 year: 2017 end-page: 29201 ident: bib0690 article-title: Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia publication-title: Oncotarget contributor: fullname: Wellbrock – volume: 110 start-page: 2880 year: 2007 end-page: 2888 ident: bib1035 article-title: STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells publication-title: Blood contributor: fullname: Vellenga – volume: 19 start-page: 1738 year: 2018 ident: bib0145 article-title: Functional regulation of PPARs through post-translational modifications publication-title: Int. J. Mol. Sci. contributor: fullname: Xu – volume: 114 start-page: 3983 year: 2009 end-page: 3993 ident: bib0480 article-title: Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal publication-title: Blood contributor: fullname: Humphries – volume: 20 start-page: 13 year: 2007 end-page: 18 ident: bib0590 article-title: The leukemic stem cell publication-title: Best Pract. Res. Clin. Haematol. contributor: fullname: Jordan – volume: 99 start-page: 1277 year: 2014 end-page: 1284 ident: bib0940 article-title: Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials publication-title: Haematologica contributor: fullname: Jordan – volume: 29 start-page: 437 year: 2006 end-page: 443 ident: bib0990 article-title: Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells publication-title: Int. J. Oncol. contributor: fullname: Yamazaki – volume: 31 start-page: 292 year: 2017 end-page: 300 ident: bib1185 article-title: Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia publication-title: Leukemia contributor: fullname: Piazza – volume: 21 start-page: 71 year: 2011 end-page: 85 ident: bib1105 article-title: Non-canonical NF-κB signaling pathway publication-title: Cell Res. contributor: fullname: Sun – volume: 9 start-page: e96698 year: 2014 ident: bib0565 article-title: The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells publication-title: PLoS One contributor: fullname: Li – volume: 12 start-page: 72 year: 2019 ident: bib1095 article-title: Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML publication-title: J. Hematol. Oncol. contributor: fullname: Burchert – volume: 29 start-page: 233 year: 2004 end-page: 242 ident: bib0140 article-title: Advances in protein kinase B signalling: AKTion on multiple fronts publication-title: Trends Biochem. Sci. contributor: fullname: Hemmings – volume: 107 start-page: 1422 year: 2016 end-page: 1429 ident: bib0340 article-title: Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells publication-title: Cancer Sci. contributor: fullname: Kakiuchi – volume: 20 start-page: 2147 year: 2006 end-page: 2154 ident: bib0350 article-title: Perfis de expressão genética de células-tronco derivadas da LMA; semelhança com células-tronco hematopoiéticas publication-title: Leucemia contributor: fullname: Trakhtenbrot – volume: 9 start-page: 513 year: 2002 end-page: 526 ident: bib1270 article-title: Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity publication-title: Cell Death Differ. contributor: fullname: Inukai – volume: 2 start-page: 17ra9 year: 2010 ident: bib0995 article-title: Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells publication-title: Sci. Transl. Med. contributor: fullname: Hijikata – volume: 19 start-page: 2628 year: 2000 end-page: 2637 ident: bib0265 article-title: Serine phosphorylation of STATs publication-title: Oncogene contributor: fullname: Kovarik – volume: 1 start-page: 5 year: 2013 ident: bib0345 article-title: Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application publication-title: Biomark. Res. contributor: fullname: Liu – volume: 8 start-page: 114 year: 2015 ident: bib1160 article-title: The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia publication-title: J. Hematol. Oncol. contributor: fullname: Oliver – volume: 8 start-page: 1403 year: 2019 ident: bib0405 article-title: Wnt signalling in acute myeloid leukaemia publication-title: Cells contributor: fullname: Alcalay – volume: 2011 start-page: 428960 year: 2011 ident: bib0635 article-title: Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia publication-title: Leuk. Res. Treatment contributor: fullname: Schmidt-Wolf – volume: 9 start-page: 24 year: 2018 ident: bib0930 article-title: NF-kappaB: two sides of the same coin publication-title: Genes contributor: fullname: Abdelhay – volume: 21 start-page: 1 year: 2007 end-page: 8 ident: bib0095 article-title: Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways publication-title: Toxicol. In Vitro contributor: fullname: Silveira – volume: 110 start-page: 4427 year: 2016 end-page: 4435 ident: bib0450 article-title: An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells publication-title: Blood contributor: fullname: Jordan – volume: 1 start-page: 89 year: 2010 end-page: 103 ident: bib0800 article-title: The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients publication-title: Oncotarget contributor: fullname: McCubrey – volume: 6 start-page: 5490 year: 2015 end-page: 5500 ident: bib1365 article-title: Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target publication-title: Oncotarget contributor: fullname: Chng – volume: 70 start-page: 4949 year: 2010 end-page: 4960 ident: bib1180 article-title: Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia publication-title: Cancer Res. contributor: fullname: Safe – volume: 6 start-page: 377 year: 2001 end-page: 388 ident: bib1245 article-title: Mechanism of fenretinide (4-HPR)-induced cell death publication-title: Apoptosis: Int. J. Programmed Cell Death contributor: fullname: Hsieh – volume: 127 start-page: 1202 year: 2017 end-page: 1214 ident: bib0285 article-title: Distinct but complementary contributions of PPAR isotypes to energy homeostasis publication-title: J. Clin. Invest. contributor: fullname: Lefebvre – volume: 105 start-page: 697 year: 2020 end-page: 707 ident: bib0465 article-title: Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models publication-title: Haematologica contributor: fullname: Dail – volume: 39 start-page: 897 year: 2015 end-page: 905 ident: bib1140 article-title: STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells publication-title: Leuk. Res. contributor: fullname: Yokoyama – volume: 114 start-page: 4359 year: 2001 end-page: 4369 ident: bib0850 article-title: Smad regulation in TGF-beta signal transduction publication-title: J. Cell. Sci. contributor: fullname: Heldin – volume: 8 start-page: 104367 year: 2017 end-page: 104392 ident: bib0250 article-title: Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells publication-title: Oncotarget contributor: fullname: Vidal – volume: 32 start-page: 4331 year: 2013 end-page: 4342 ident: bib0680 article-title: Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia publication-title: Oncogene contributor: fullname: Kroemer – volume: 102 start-page: 972 year: 2003 end-page: 980 ident: bib1255 article-title: Survival of acute myeloid leukemia cells requires PI3 kinase activation publication-title: Blood contributor: fullname: Carroll – volume: 25 start-page: 1064 year: 2019 end-page: 1072 ident: bib0205 article-title: T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant publication-title: Nat. Med. contributor: fullname: Bar – volume: 1 start-page: 8 year: 2009 ident: bib0670 article-title: Novel insights into the differential functions of Notch ligands in vascular formation publication-title: J. Angiogenes. Res. contributor: fullname: Kume – volume: 13 start-page: 1979 year: 2014 end-page: 1990 ident: bib0445 article-title: Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia publication-title: Mol. Cancer Ther. contributor: fullname: Sharma – volume: 75 start-page: 1343 year: 2012 end-page: 1356 ident: bib1235 article-title: Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells publication-title: J. Proteomics contributor: fullname: Daub – volume: 125 start-page: 2863 year: 2009 end-page: 2870 ident: bib0050 article-title: Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt publication-title: Int. J. Cancer contributor: fullname: Vogt – volume: 24 start-page: 2417 year: 2018 end-page: 2429 ident: bib0570 article-title: Disruption of wnt/β-Catenin exerts antileukemia activity and synergizes with FLT3 inhibition in publication-title: Clin. Cancer Res. contributor: fullname: Carter – volume: 12 start-page: 548 year: 2012 end-page: 584 ident: bib0820 article-title: Biology and therapeutic applications of peroxisome proliferator- activated receptors publication-title: Curr. Top. Med. Chem. contributor: fullname: Ricote – volume: 127 start-page: 1163 year: 2016 end-page: 1172 ident: bib0475 article-title: LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia publication-title: Blood contributor: fullname: Basso – year: 2020 ident: bib1000 article-title: Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia publication-title: Cancer Cell contributor: fullname: Wang – volume: 34 start-page: 724 year: 2018 end-page: 740.e4 ident: bib0585 article-title: Inhibition of amino acid metabolism selectively targets human leukemia stem cells publication-title: Cancer Cell contributor: fullname: D’Alessandro – volume: 72 start-page: 379 year: 2012 end-page: 386 ident: bib0210 article-title: JNK-induced apoptosis, compensatory growth, and cancer stem cells publication-title: Cancer Res. contributor: fullname: Chen – volume: 11 start-page: 928 year: 2020 ident: bib1065 article-title: FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML publication-title: Nat. Commun. contributor: fullname: Qian – volume: 109 start-page: S121 year: 2002 end-page: S131 ident: bib0880 article-title: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway publication-title: Cell contributor: fullname: Schreiber – volume: 30 start-page: 395 year: 2013 ident: bib0270 article-title: PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity publication-title: Med. Oncol. (Northwood, London, England) contributor: fullname: Chen – volume: 114 start-page: 937 year: 2009 end-page: 951 ident: bib1200 article-title: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes publication-title: Blood contributor: fullname: Bloomfield – volume: 6 start-page: 91 year: 2004 end-page: 99 ident: bib1060 article-title: The LKB1 tumor suppressor negatively regulates mTOR signaling publication-title: Cancer Cell contributor: fullname: Cantley – volume: 6 start-page: 1 year: 2015 end-page: 12 ident: bib0355 article-title: Notch signal strength controls cell fate in the haemogenic endothelium publication-title: Nat. Commun. contributor: fullname: Maeda – volume: 142 start-page: 164 year: 2014 end-page: 175v ident: bib0935 article-title: Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway publication-title: Pharmacol. Ther. contributor: fullname: Janku – volume: 28 start-page: 573 year: 2003 end-page: 576 ident: bib0790 article-title: Rheb fills a GAP between TSC and TOR publication-title: Trends Biochem. Sci. contributor: fullname: Cantley – volume: 4 start-page: e312 year: 2020 ident: bib1040 article-title: Phospho-profiling linking biology and clinics in pediatric acute myeloid leukemia publication-title: Hemasphere contributor: fullname: Dworzak – volume: 41 start-page: 858 year: 2013 end-page: 869.e 4 ident: bib0125 article-title: Nonhematopoietic cells represent a more rational target of in vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors publication-title: Exp. Hematol. contributor: fullname: Bhatia – volume: 34 start-page: 115 year: 2009 end-page: 127 ident: bib0645 article-title: Regulation of phosphoinositide 3-kinase expression in health and disease publication-title: Trends Biochem. Sci. contributor: fullname: Vanhaesebroeck – volume: 32 start-page: 1313 year: 2014 end-page: 1322 ident: bib0495 article-title: Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness publication-title: Stem Cells (Dayton, Ohio) contributor: fullname: Oh – volume: 5 start-page: 253 year: 2004 ident: bib1275 article-title: The Janus kinases (Jaks) publication-title: Genome Biol. contributor: fullname: O’Shea – volume: 13 start-page: 2422 year: 2014 end-page: 2435 ident: bib0455 article-title: Piperlongumine chemosensitizes tumor cells through interaction with cysteine 179 of IκBα kinase, leading to suppression of NF-κB-regulated gene products publication-title: Mol. Cancer Ther. contributor: fullname: Aggarwal – volume: 463 start-page: 676 year: 2010 end-page: 680 ident: bib0860 article-title: TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia publication-title: Nature contributor: fullname: Hirao – volume: 3 start-page: 24 year: 2002 end-page: 33 ident: bib0025 article-title: Hedgehog–Gli signaling and the growth of the-brain publication-title: Nat. Rev. Neurosci. contributor: fullname: Dahmane – volume: 57 start-page: 17 year: 1999 end-page: 26 ident: bib0485 article-title: Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60 publication-title: Oncology contributor: fullname: Mu – volume: 97 start-page: 2177 year: 2001 end-page: 2179 ident: bib0430 article-title: Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells publication-title: Blood contributor: fullname: Grimes – volume: 34 start-page: 1420 year: 2013 end-page: 1430 ident: bib0155 article-title: The Notch signaling pathway as a mediator of tumor survival publication-title: Carcinogenesis contributor: fullname: Pine – volume: 315 start-page: 3004 year: 2009 end-page: 3013 ident: bib1010 article-title: Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis publication-title: Exp. Cell Res. contributor: fullname: Munell – volume: 18 start-page: 606 year: 2010 end-page: 618 ident: bib1290 article-title: β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells publication-title: Cancer Cell contributor: fullname: So – volume: 483656 year: 2012 ident: bib1115 article-title: Effects of PPARγ ligands on leukemia publication-title: PPAR Res. contributor: fullname: Ohsaka – volume: 106 start-page: djt440 year: 2014 ident: bib0170 article-title: Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents publication-title: J. Natl. Cancer Inst. contributor: fullname: Mak – volume: 32 start-page: 1550 year: 2011 end-page: 1558 ident: bib0490 article-title: Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation publication-title: Carcinogenesis contributor: fullname: Zhou – volume: 8 start-page: 627 year: 2009 end-page: 644 ident: bib0735 article-title: Targeting the phosphoinositide 3-kinase pathway in cancer publication-title: Nat. Rev. Drug Discov. contributor: fullname: Zhao – volume: 35 start-page: 6045 year: 2016 end-page: 6052 ident: bib0785 article-title: Targeting CK2-driven non-oncogene addiction in B-cell tumors publication-title: Oncogene contributor: fullname: Piazza – volume: 38 start-page: 1288 year: 2016 end-page: 1302 ident: bib0755 article-title: Targeting GLI1 suppresses cell growth and enhances chemosensitivity in CD34+ enriched acute myeloid leukemia progenitor cells publication-title: Cell. Physiol. Biochem. contributor: fullname: Liu – volume: 99 start-page: 141 year: 2016 end-page: 149 ident: bib0290 article-title: The Wnt signaling pathway in cancer publication-title: Crit. Rev. Oncol. Hematol. contributor: fullname: Kahn – volume: 70 start-page: 2516 year: 2010 end-page: 2527 ident: bib0580 article-title: Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species publication-title: Cancer Res. contributor: fullname: Pan – volume: 13 start-page: 449 year: 2015 end-page: 460 ident: bib0015 article-title: MUC1-C induces the LIN28B→LET-7→HMGA2 Axis to regulate self-renewal in NSCLC publication-title: Mol. Cancer Res. MCR contributor: fullname: Kufe – volume: 8 start-page: 22 year: 2016 ident: bib0965 article-title: Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors publication-title: Cancers contributor: fullname: Lo – volume: 7 start-page: 29804 year: 2016 end-page: 29823 ident: bib0410 article-title: Notch signaling: its roles and therapeutic potential in hematological malignancies publication-title: Oncotarget contributor: fullname: Banham – volume: 16 start-page: 455 year: 2005 end-page: 459 ident: bib0730 article-title: Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro publication-title: Ann. Oncol. contributor: fullname: Lin – volume: 1 start-page: 13 year: 2014 ident: bib1345 article-title: Reactive oxygen species in eradicating acute myeloid leukemic stem cells publication-title: Stem Cell Investig. contributor: fullname: Wang – volume: 16 start-page: 1134 year: 2016 end-page: 1166 ident: bib1080 article-title: Review on EGFR inhibitors: critical updates publication-title: Mini Rev. Med. Chem. contributor: fullname: Bariwal – volume: 16 start-page: 13 year: 2017 ident: bib1085 article-title: Targeting acute myeloid leukemia stem cell signaling by natural products publication-title: Mol. Cancer contributor: fullname: Mohammad – volume: 211 start-page: 1093 year: 2014 end-page: 1108 ident: bib1215 article-title: Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML publication-title: J. Exp. Med. contributor: fullname: Zhang – volume: 2 start-page: 47 year: 2013 end-page: 63 ident: bib1240 article-title: The TGFbeta superfamily signaling pathway. Wiley interdisciplinary reviews publication-title: Dev. Biol. contributor: fullname: Attisano – volume: 95 start-page: 71 year: 2010 end-page: 78 ident: bib1355 article-title: Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia publication-title: Haematologica contributor: fullname: Pardoux – volume: 19 start-page: 717 year: 2019 end-page: 729 ident: bib0980 article-title: Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia publication-title: Expert Rev. Anticancer Ther. contributor: fullname: Amer – volume: 12 start-page: 3 year: 2018 end-page: 20 ident: bib1075 article-title: Emerging functions of the EGFR in cancer publication-title: Mol. Oncol. contributor: fullname: Lanzetti – year: 2008 ident: bib1110 article-title: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissue contributor: fullname: Harris – volume: 54 start-page: 955 year: 2010 end-page: 963 ident: bib0180 article-title: Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells publication-title: Int. J. Dev. Biol. contributor: fullname: Bhatia – volume: 97 start-page: 966 year: 2012 end-page: 974 ident: bib0500 article-title: Recent advances in acute myeloid leukemia stem cell biology publication-title: Haematologica contributor: fullname: Huntly – volume: 12 start-page: 1167 year: 2006 end-page: 1174 ident: bib0575 article-title: Targeting of CD44 eradicates human acute myeloid leukemic stem cells publication-title: Nat. Med. contributor: fullname: Dick – volume: 7 start-page: 708 year: 2010 end-page: 717 ident: bib0625 article-title: TIM-3 is a promising target to selectively kill acute myeloid Leukemia stem cells publication-title: Cell Stem Cell contributor: fullname: Takayanagi – volume: 39 start-page: 145 year: 2019 end-page: 158 ident: bib1350 article-title: Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9 publication-title: EBioMedicine contributor: fullname: Lum – volume: 114 start-page: 1498 year: 2009 end-page: 1505 ident: bib0970 article-title: Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis publication-title: Blood contributor: fullname: Schuringa – volume: 9 start-page: 1358 year: 2019 ident: bib1285 article-title: Donor-derived CD123-Targeted CAR t cell serves as a RIC regimen for haploidentical transplantation in a patient with publication-title: Front. Oncol. contributor: fullname: Yarong – volume: 94 start-page: 1370 year: 2014 end-page: 1381 ident: bib1305 article-title: C. miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells publication-title: Lab. Invest. contributor: fullname: Lee – volume: 30 start-page: 1009 year: 2011 end-page: 1019 ident: bib0775 article-title: Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells publication-title: Oncogene contributor: fullname: Majeti – volume: 10 start-page: 215 year: 2006 end-page: 226 ident: bib0375 article-title: Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival publication-title: Cancer Cell contributor: fullname: Hunter – year: 2001 ident: bib0555 article-title: World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissue contributor: fullname: Stein – volume: 8 year: 2012 ident: bib0010 article-title: Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia publication-title: PLoS Genet. contributor: fullname: Figueroa – volume: 7 start-page: 397 year: 2004 end-page: 402 ident: bib0855 article-title: PPAR trilogy from metabolism to cancer publication-title: Curr. Opin. Clin. Nutr. Metab. Care contributor: fullname: Nahlé – volume: 98 start-page: 2301 year: 2001 end-page: 2307 ident: bib0425 article-title: Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells publication-title: Blood contributor: fullname: Jordan – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib0135 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. contributor: fullname: Jemal – volume: 110 start-page: 163 year: 2002 end-page: 175 ident: bib0630 article-title: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery publication-title: Cell contributor: fullname: Sabatini – volume: 91 start-page: 757 year: 2006 end-page: 764 ident: bib0060 article-title: Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry publication-title: Haematologica contributor: fullname: Lacombe – volume: 9 start-page: 550 year: 2009 end-page: 562 ident: bib0295 article-title: Targeting PI3K signalling in cancer: opportunities, challenges and limitations publication-title: Nat. Rev. Cancer contributor: fullname: Engelman – volume: 20 start-page: 182 year: 2019 end-page: 194 ident: bib0890 article-title: A novel platinum complex containing a piplartine derivative exhibits enhanced cytotoxicity, causes oxidative stress and triggers apoptotic cell death by ERK/p38 pathway in human acute promyelocytic leukemia HL-60 cells publication-title: Redox Biol. contributor: fullname: Villarreal – volume: 2 start-page: 16042 year: 2017 ident: bib0020 article-title: The paradoxical functions of EGFR during breast cancer progression publication-title: Signal Transduct. Target. Ther. contributor: fullname: Wendt – volume: 106 start-page: 3396 year: 2009 end-page: 3401 ident: bib0780 article-title: Dysregulated gene expression networks in human acute myelogenous leukemia stem cells publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Weissman – volume: 60 start-page: 1085 year: 2000 end-page: 1089 ident: bib0120 article-title: Nuclear factor-kappa B, cancer, and apoptosis publication-title: Biochem. Pharmacol. contributor: fullname: Merville – volume: 20 start-page: 1456 year: 2019 end-page: 1468 ident: bib0215 article-title: RBPJ-dependent Notch signaling initiates the T cell program in a subset of thymus-seeding progenitors publication-title: Nat. Immunol. contributor: fullname: Zúñiga-Pflücker – volume: 18 start-page: 8 year: 2018 ident: bib1090 article-title: The role of the Hedgehog signaling pathway in cancer: a comprehensive review publication-title: Bosn. J. Basic Med. Sci. contributor: fullname: Serman – volume: 14 start-page: 1236 year: 2012 end-page: 1248 ident: bib0065 article-title: Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells publication-title: Neoplasia (New York, N.Y.) contributor: fullname: Cairoli – volume: 6 start-page: 25476 year: 2016 ident: bib0540 article-title: Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia publication-title: Sci. Rep. contributor: fullname: Kinstrie – volume: 37 start-page: 3675 year: 2016 end-page: 3681 ident: bib1230 article-title: TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells publication-title: Tumour Biol. contributor: fullname: Li – volume: 114 start-page: E4574 year: 2017 end-page: E4581 ident: bib0035 article-title: Selective regulation of Notch ligands during angiogenesis is mediated by vimentin publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Sahlgren – volume: 8 start-page: 8420 year: 2017 end-page: 8435 ident: bib0720 article-title: Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling publication-title: Oncotarget contributor: fullname: Zhang – volume: 511 start-page: 90 year: 2014 end-page: 93 ident: bib1320 article-title: The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation publication-title: Nature contributor: fullname: Borden – volume: 48 start-page: 453 year: 2013 end-page: 463 ident: bib0100 article-title: Overview of the therapeutic potential of piplartine (piperlongumine) publication-title: Eur. J. Pharm. Sci. contributor: fullname: Costa-Lotufo – volume: 73 start-page: 373 year: 2013 end-page: 384 ident: bib1145 article-title: STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2 publication-title: Cancer Res. contributor: fullname: Kindler – volume: 15 start-page: 294 year: 2017 end-page: 303 ident: bib1370 article-title: LIN28B activation by PRL-3 promotes leukemogenesis and a stem cell-like transcriptional program in AML publication-title: Mol. Cancer Res. MCR contributor: fullname: Chng – volume: 100 start-page: 336 year: 2015 end-page: 344 ident: bib0875 article-title: Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia publication-title: Haematologica contributor: fullname: Geiger – volume: 19 start-page: 2783 year: 2005 end-page: 2810 ident: bib0810 article-title: Smad transcription factors publication-title: Genes Dev. contributor: fullname: Wotton – volume: 105 start-page: 4163 year: 2014 end-page: 4169 ident: bib0440 article-title: The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells publication-title: Blood contributor: fullname: Jordan – volume: 18 start-page: 1350 year: 2012 end-page: 1358 ident: bib0545 article-title: A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance publication-title: Nat. Med. contributor: fullname: Pandolfi – volume: 441 start-page: 431 year: 2006 end-page: 436 ident: bib0615 article-title: Nuclear factor-kappaB in cancer development and progression publication-title: Nature contributor: fullname: Karin – volume: 25 start-page: 903 year: 2007 end-page: 915 ident: bib1005 article-title: PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase publication-title: Mol. Cell contributor: fullname: Sabatini – volume: 27 start-page: 1548 year: 2013 end-page: 1557 ident: bib0395 article-title: Notch signaling in acute promyelocytic leukemia publication-title: Leukemia contributor: fullname: Ley – volume: 10 start-page: 556 year: 2019 ident: bib0925 article-title: Non-canonical hedgehog signaling pathway in cancer: activation of GLI transcription factors beyond smoothened publication-title: Front. Genet. contributor: fullname: Stecca – volume: 53 start-page: 409 year: 2002 end-page: 435 ident: bib0090 article-title: The mechanisms of action of PPARs publication-title: Annu. Rev. Med. contributor: fullname: Moller – volume: 19 start-page: 206 year: 2019 end-page: 212 ident: bib0370 article-title: Adding oral pioglitazone to standard induction chemotherapy of acute myeloid leukemia: a randomized clinical trial publication-title: Clin. Lymphoma Myeloma Leuk. contributor: fullname: Salari – volume: 7 start-page: 33004 year: 2016 end-page: 33015 ident: bib0715 article-title: Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells publication-title: Oncotarget contributor: fullname: Meng – volume: 39 start-page: 830 year: 2018 end-page: 847 ident: bib0195 article-title: Canonical and non-canonical wnt signaling in immune cells publication-title: Trends Immunol. contributor: fullname: Bothwell – volume: 99 start-page: 16220 year: 2002 end-page: 16225 ident: bib0435 article-title: Preferential induction of apoptosis for primary human leukemic stem cells publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Jordan – volume: 110 start-page: 2659 year: 2007 end-page: 2666 ident: bib1195 article-title: The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells publication-title: Blood contributor: fullname: Kelder – start-page: 103 year: 2019 end-page: 120 ident: bib0115 article-title: Targeting the hedgehog and notch signaling pathways in cancer stem cells publication-title: Oncogenomics contributor: fullname: Kumar – volume: 38 start-page: 687 year: 2019 end-page: 698 ident: bib0695 article-title: Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity publication-title: Oncogene contributor: fullname: Madero-Marroquin – volume: 27 start-page: 5497 year: 2008 end-page: 5510 ident: bib1310 article-title: PI3K pathway alterations in cancer: variations on a theme publication-title: Oncogene contributor: fullname: Cantley – volume: 117 start-page: 5918 year: 2011 end-page: 5930 ident: bib0945 article-title: Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation publication-title: Blood contributor: fullname: Karlsson – volume: 139 start-page: 95 year: 2013 end-page: 110 ident: bib0305 article-title: Notch inhibitors for cancer treatment publication-title: Pharmacol. Ther. contributor: fullname: Miele – volume: 33 start-page: 2379 year: 2019 end-page: 2392 ident: bib0955 article-title: CD8 publication-title: Leukemia contributor: fullname: Ochsenbein – volume: 210 start-page: 301 year: 2013 end-page: 319 ident: bib0745 article-title: Notch pathway activation targets AML-initiating cell homeostasis and differentiation publication-title: J. Exp. Med. contributor: fullname: Aifantis – volume: 12 start-page: eaaz8264 year: 2020 ident: bib0830 article-title: The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability publication-title: Sci. Transl. Med. contributor: fullname: Voisin – volume: 5 start-page: 4337 year: 2014 end-page: 4346 ident: bib0840 article-title: XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells publication-title: Oncotarget contributor: fullname: Risueño – volume: 18 start-page: 1926 year: 2004 end-page: 1945 ident: bib0470 article-title: Upstream and downstream of mTOR publication-title: Genes Dev. contributor: fullname: Sonenberg – volume: 33 start-page: 451 year: 1976 end-page: 458 ident: bib0070 article-title: Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group publication-title: Br. J. Haematol. contributor: fullname: Sultan – volume: 19 start-page: 586 year: 2005 end-page: 594 ident: bib0385 article-title: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways publication-title: Leukemia contributor: fullname: Khwaja – volume: 30 start-page: 1 year: 2020 end-page: 13 ident: bib1125 article-title: Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present) publication-title: Expert Opin. Ther. Pat. contributor: fullname: Makishima – volume: 13 start-page: 98 year: 2015 ident: bib0985 article-title: GLI2 inhibition abrogates human leukemia stem cell dormancy publication-title: J. Transl. Med. contributor: fullname: Jamieson – volume: 7 year: 2015 ident: bib0725 article-title: Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia publication-title: Sci. Transl. Med. contributor: fullname: Matsui – volume: 110 start-page: 5606 year: 2013 end-page: 5611 ident: bib1340 article-title: Preferential eradication of acute myelogenous leukemia stem cells by fenretinide publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Wang – volume: 7 start-page: 606 year: 2006 end-page: 619 ident: bib0300 article-title: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism publication-title: Nat. Rev. Genet. contributor: fullname: Cantley – volume: 16 start-page: 27 year: 2000 end-page: 33 ident: bib0900 article-title: TGF beta-related pathways. Roles in Caenorhabditis elegans development publication-title: Trends Genetics: TIG contributor: fullname: Padgett – volume: 26 start-page: 1174 year: 2012 end-page: 1179 ident: bib0920 article-title: Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways publication-title: Leukemia contributor: fullname: Semenzato – volume: 19 start-page: 1933 year: 2013 end-page: 1940 ident: bib0950 article-title: Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance publication-title: Clin. Cancer Res. contributor: fullname: Verstovsek – volume: 93 start-page: 241 year: 1998 end-page: 252 ident: bib1165 article-title: PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL publication-title: Cell contributor: fullname: Evans – volume: 8 start-page: 147 year: 2019 ident: bib0870 article-title: Gli proteins: regulation in development and cancer publication-title: Cells contributor: fullname: Chojnowska – volume: 29 start-page: 214 year: 2016 end-page: 228 ident: bib0700 article-title: miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells publication-title: Cancer Cell contributor: fullname: Ng – volume: 23 start-page: 14 year: 2015 end-page: 21 ident: bib0185 article-title: Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment? publication-title: Saudi Pharm. J. contributor: fullname: Yilmaz – volume: 210 start-page: 321 year: 2013 end-page: 337 ident: bib0605 article-title: Notch activation inhibits AML growth and survival: a potential therapeutic approach publication-title: J. Exp. Med. contributor: fullname: Zweidler-McKay – volume: 9 start-page: 582 year: 2019 ident: bib0055 article-title: Ruthenium complexes with piplartine cause apoptosis through MAPK signaling by a p53-dependent pathway in human colon carcinoma cells and inhibit tumor development in a xenograft model publication-title: Front. Oncol. contributor: fullname: Bezerra – volume: 26 start-page: 1631 year: 2009 end-page: 1640 ident: bib1155 article-title: Evolutionary scenarios of Notch proteins publication-title: Mol. Biol. Evol. contributor: fullname: Kossida – volume: 164 start-page: 481 year: 2014 end-page: 495 ident: bib0365 article-title: Antibody therapy for acute myeloid leukaemia publication-title: Br. J. Haematol. contributor: fullname: Hart – volume: 23 start-page: 3385 year: 2017 end-page: 3395 ident: bib0460 article-title: Antileukemia efficacy and mechanisms of action of SL-101, a novel Anti-CD123 antibody conjugate, in acute myeloid leukemia publication-title: Clin. Cancer Res. contributor: fullname: Brooks – volume: 115 start-page: 279 year: 2001 end-page: 286 ident: bib0865 article-title: Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis publication-title: Br. J. Haematol. contributor: fullname: Huang – year: 2020 ident: bib0030 article-title: Cancer Facts & Figures 2020 contributor: fullname: American Cancer Society – volume: 14 start-page: 1777 year: 2000 end-page: 1784 ident: bib0595 article-title: The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells publication-title: Leukemia contributor: fullname: Szilvassy – volume: 16 start-page: 797 year: 2005 end-page: 803 ident: bib0845 article-title: PI3K/Akt/mTOR pathway as a target for cancer therapy publication-title: Anticancer Drugs contributor: fullname: McLeod – volume: 34 start-page: 1027 year: 2020 end-page: 1037 ident: bib0320 article-title: Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis publication-title: Leukemia contributor: fullname: Buske – volume: 61 start-page: 5307 year: 2001 end-page: 5310 ident: bib0525 article-title: Mutational analysis of the peroxisome proliferator-activated receptor γ in human malignancies publication-title: Cancer Res. contributor: fullname: Kawano – volume: 103 start-page: 460 year: 1985 end-page: 462 ident: bib0080 article-title: Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group publication-title: Ann. Intern. Med. contributor: fullname: Sultan – volume: 9 start-page: eaaj2025 year: 2017 ident: bib0235 article-title: CD99 is a therapeutic target on disease stem cells in myeloid malignancies publication-title: Sci. Transl. Med. contributor: fullname: Hu – volume: 109 start-page: 15115 year: 2012 end-page: 15120 ident: bib0005 article-title: Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Shamji – volume: 11 start-page: 95 year: 2010 end-page: 110 ident: bib0175 article-title: Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology publication-title: Curr. Drug Targets contributor: fullname: Helfrich – volume: 104 start-page: 11008 year: 2007 end-page: 11013 ident: bib0510 article-title: CD96 is a specific marker of leukemic stem cells in acute human myeloid leukemia publication-title: Proc. Natl. Acad. Sci. U.S.A. contributor: fullname: Tatsumi – volume: 446 start-page: 475 year: 2005 end-page: 482 ident: bib0275 article-title: NF-kB in development and progression of human cancer publication-title: Virchows Archiv: Int. J. Pathol. contributor: fullname: Matias-Guiu – volume: 38 start-page: 308 year: 2019 ident: bib1150 article-title: Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms publication-title: J. Experim. Clin. Cancer Res. CR contributor: fullname: Wu – volume: 123 start-page: 2826 year: 2014 end-page: 2837 ident: bib0245 article-title: Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells publication-title: Blood contributor: fullname: Bhatia – volume: 27 start-page: 6473 year: 2008 end-page: 6488 ident: bib0335 article-title: PI3K/Akt: getting it right matters publication-title: Oncogene contributor: fullname: Franke – volume: 5 start-page: 504 year: 2009 end-page: 514 ident: bib0535 article-title: Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors publication-title: Cell Stem Cell contributor: fullname: Miyazono – volume: 34 start-page: 1420 year: 2013 end-page: 1430 ident: bib0160 article-title: The Notch signaling pathway as a mediator of tumor survival publication-title: Carcinogenesis contributor: fullname: Pine – volume: 128 start-page: 2317 year: 2011 end-page: 2325 ident: bib0530 article-title: Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents publication-title: Int. J. Cancer contributor: fullname: Yokoyama – volume: 7 start-page: 519 year: 2011 end-page: 541 ident: bib0220 article-title: The landscape of EGFR pathways and personalized management of non-small-cell lung cancer publication-title: Future Oncol. (London, England) contributor: fullname: Lopez-Beltran – volume: 94 start-page: 950 year: 2014 end-page: 965 ident: bib1210 article-title: Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer publication-title: Lab. Invest. contributor: fullname: Merlin – volume: 124 start-page: 1777 year: 2014 end-page: 1789 ident: bib0415 article-title: PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene publication-title: Blood contributor: fullname: Huang – volume: 7 start-page: 1554 year: 2015 end-page: 1585 ident: bib0240 article-title: Hedgehog signaling in the maintenance of cancer stem cells publication-title: Cancers contributor: fullname: Cain – volume: 25 start-page: 203 year: 2007 end-page: 210 ident: bib0190 article-title: Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells publication-title: Stem cells (Dayton, Ohio) contributor: fullname: Buckle – volume: 26 start-page: 650 year: 2017 end-page: 661 ident: bib1170 article-title: Modulating the wnt signaling pathway with small molecules publication-title: Protein Sci. contributor: fullname: Zheng – volume: 459 start-page: 692 year: 2015 end-page: 698 ident: bib0520 article-title: Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia publication-title: Biochem. Biophys. Res. Commun. contributor: fullname: Yuan – volume: 1799 start-page: 775 year: 2010 end-page: 787 ident: bib0420 article-title: Inhibiting NF-κB activation by small molecules as a therapeutic strategy publication-title: Biochim. Biophys. Acta contributor: fullname: Aggarwal – volume: 4 start-page: 68 year: 2008 end-page: 75 ident: bib0650 article-title: Wnt signal transduction pathways publication-title: Organogenesis contributor: fullname: Habas – volume: 22 start-page: 350 year: 2018 end-page: 358 ident: bib1250 article-title: Stabilization of NF-κB-Inducing kinase suppresses MLL-AF9-Induced acute myeloid leukemia publication-title: Cell Rep. contributor: fullname: Zhao – volume: 133 start-page: 1967 year: 2013 end-page: 1981 ident: bib1280 article-title: IL-1β inhibits self-renewal capacity of dormant CD34 publication-title: Int. J. Cancer contributor: fullname: Yokoyama – volume: 7 start-page: 61 year: 2016 ident: bib0975 article-title: Telomerase activation in hematological malignancies publication-title: Genes (Basel). contributor: fullname: Chevret – volume: 98 start-page: 627 year: 2013 end-page: 633 ident: bib0620 article-title: TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells publication-title: Int. J. Hematol. contributor: fullname: Miyamoto – volume: 185 start-page: 595 year: 2019 end-page: 598 ident: bib0105 article-title: Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial publication-title: Br. J. Haematol. contributor: fullname: Colburn – volume: 19 start-page: 717 year: 2019 end-page: 729 ident: bib1050 article-title: Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia publication-title: Expert Rev. Anticancer Ther. contributor: fullname: Zeidan – volume: 42 start-page: S20 year: 2014 ident: bib0230 article-title: CD99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes publication-title: Exp. Hematol. contributor: fullname: Park – volume: 21 start-page: 656 year: 2009 end-page: 664 ident: bib0815 article-title: Akt-dependent and -independent mechanisms of mTOR regulation in cancer publication-title: Cell. Signal. contributor: fullname: Dennis – volume: 29 start-page: 1267 year: 2015 end-page: 1278 ident: bib0330 article-title: Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells publication-title: Leukemia contributor: fullname: Bhalla – volume: 8 start-page: e2797 year: 2017 ident: bib1265 article-title: Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2 publication-title: Cell Death Dis. contributor: fullname: Wang – volume: 104 start-page: 2006 year: 2019 end-page: 2016 ident: bib0200 article-title: Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells publication-title: Haematologica contributor: fullname: Järås – volume: 10 start-page: 457 year: 2002 end-page: 468 ident: bib0750 article-title: Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control publication-title: Mol. Cell contributor: fullname: Hall – volume: 26 start-page: 344 year: 2012 end-page: 349 ident: bib1175 article-title: Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains publication-title: Genes Dev. contributor: fullname: Orkin – volume: 7 start-page: 208 year: 2018 ident: bib1020 article-title: Hedgehog signaling in cancer: a prospective therapeutic target for eradicating Cancer stem cells publication-title: Cells contributor: fullname: Kwon – volume: 28 start-page: 1099 year: 2009 end-page: 1109 ident: bib0400 article-title: ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia publication-title: Oncogene contributor: fullname: Adès – volume: 77 start-page: 7103 year: 2012 end-page: 7107 ident: bib1335 article-title: Biomimetic semisynthesis of arglabin from parthenolide publication-title: J. Org. Chem. contributor: fullname: Chen – volume: 367 start-page: 645 year: 1994 end-page: 648 ident: bib0685 article-title: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice publication-title: Nature contributor: fullname: Dick – volume: 21 start-page: 1638 year: 2007 end-page: 1647 ident: bib0825 article-title: The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia publication-title: Leukemia contributor: fullname: Müller-Tidow – volume: 410 start-page: 1 year: 2008 end-page: 17 ident: bib0040 article-title: The regulation and function of Class III PI3Ks: novel roles for Vps34 publication-title: Biochem. J. contributor: fullname: Backer – volume: 11 start-page: 37 year: 2011 end-page: 48 ident: bib1190 article-title: JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia publication-title: Expert Rev. Anticancer Ther. contributor: fullname: Qazi – volume: 35 start-page: 119 year: 2011 end-page: 125 ident: bib1045 article-title: The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cells publication-title: Leuk. Res. contributor: fullname: Bug – volume: 100 start-page: 948 year: 2009 end-page: 955 ident: bib0640 article-title: Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells publication-title: Cancer Sci. contributor: fullname: Murase – volume: 22 start-page: 1698 year: 2008 end-page: 1706 ident: bib0895 article-title: PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML publication-title: Leukemia contributor: fullname: Bouscary – volume: 7 start-page: 38974 year: 2016 end-page: 38987 ident: bib1120 article-title: MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia publication-title: Oncotarget contributor: fullname: Kufe – start-page: 1083 year: 2020 end-page: 1112 ident: bib1325 article-title: Notch and its ligands publication-title: Principles of Bone Biology contributor: fullname: Canalis – volume: 17 start-page: 412 year: 2015 end-page: 421 ident: bib0550 article-title: CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-Rearranged acute myeloid leukemia publication-title: Cell Stem Cell contributor: fullname: Cleary – volume: 7 start-page: 21713 year: 2016 end-page: 21727 ident: bib1130 article-title: Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia publication-title: Oncotarget contributor: fullname: Krampera – volume: 96 start-page: 309 year: 2016 end-page: 317 ident: bib0360 article-title: Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia publication-title: Eur. J. Haematol. contributor: fullname: Madkaikar – volume: 14 start-page: 2009 year: 2007 end-page: 2023 ident: bib0795 article-title: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside publication-title: Curr. Med. Chem. contributor: fullname: Cocco – volume: 121 start-page: 384 year: 2011 end-page: 395 ident: bib1025 article-title: Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice publication-title: J. Clin. Invest. contributor: fullname: Carroll – volume: 448 start-page: 439 year: 2007 end-page: 444 ident: bib0165 article-title: A transforming mutation in the pleckstrin homology domain of AKT1 in cancer publication-title: Nature contributor: fullname: Thomas – volume: 24 start-page: 2294 year: 2018 end-page: 2303 ident: bib1030 article-title: Phase ib study of Glasdegib, a hedgehog pathway inhibitor, in combination with standard chemotherapy in patients with AML or high-risk MDS publication-title: Clin. Cancer Res. contributor: fullname: Cortes – volume: 121 start-page: 5015 year: 2013 end-page: 5024 ident: bib1100 article-title: Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function publication-title: Blood contributor: fullname: Baldwin – volume: 122 start-page: 2114 year: 2012 end-page: 2129 ident: bib0515 article-title: mTORC1 is essential for leukemia propagation but not stem cell self-renewal publication-title: J. Clin. Invest. contributor: fullname: Hirao – volume: 12 start-page: 329 year: 2013 end-page: 341 ident: bib0675 article-title: BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells publication-title: Cell Stem Cell contributor: fullname: Minhajuddin – volume: 9 start-page: 64 year: 2016 ident: bib0770 article-title: Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia publication-title: J. Hematol. Oncol. contributor: fullname: de Bont – volume: 327 start-page: 1650 year: 2010 end-page: 1653 ident: bib1220 article-title: The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML publication-title: Science contributor: fullname: Armstrong – volume: 127 start-page: 53 year: 2016 end-page: 61 ident: bib0280 article-title: An update of current treatments for adult acute myeloid leukemia publication-title: Blood contributor: fullname: Gardin – volume: 1443 start-page: 54 year: 2019 end-page: 74 ident: bib0380 article-title: The Wnt signaling pathway: a potential therapeutic target against cancer publication-title: Ann. N. Y. Acad. Sci. contributor: fullname: Sil – volume: 106 start-page: 4261 year: 2005 end-page: 4268 ident: bib1260 article-title: mTOR regulates cell survival after etoposide treatment in primary AML cells publication-title: Blood contributor: fullname: Carroll – year: 2020 ident: bib0310 article-title: Epidermal growth factor receptor-dependent DNA repair promotes murine and human hematopoietic regeneration publication-title: Blood contributor: fullname: Chute – volume: 78 start-page: 325 year: 1991 end-page: 329 ident: bib0085 article-title: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) publication-title: Br. J. Haematol. contributor: fullname: Sultan – volume: 107 start-page: 1156 year: 2006 end-page: 1165 ident: bib0130 article-title: NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome publication-title: Blood contributor: fullname: Coquelle – volume: 1 start-page: 20 year: 2008 ident: bib0835 article-title: First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting publication-title: J. Hematol. Oncol. contributor: fullname: Siu – volume: 3 start-page: 651 year: 2002 end-page: 662 ident: bib0710 article-title: Stats: transcriptional control and biological impact publication-title: Nat. Rev. Mol. Cell Biol. contributor: fullname: Darnell – volume: 11 start-page: 1958 year: 2019 ident: bib1135 article-title: Notch signaling molecules as prognostic biomarkers for acute myeloid leukemia publication-title: Cancers contributor: fullname: Krampera – volume: 15 start-page: 315 year: 2009 end-page: 327 ident: bib0915 article-title: TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma publication-title: Cancer Cell contributor: fullname: Seoane – volume: 7 start-page: 55083 year: 2016 end-page: 55097 ident: bib1330 article-title: MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells publication-title: Oncotarget contributor: fullname: Konopleva – year: 2020 ident: bib0960 article-title: Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents publication-title: Nat. Med. contributor: fullname: Höpner – volume: 118 start-page: 2830 year: 2011 end-page: 2839 ident: bib1360 article-title: The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML publication-title: Blood contributor: fullname: Cheong – volume: 3 start-page: 1249 year: 2004 end-page: 1262 ident: bib0655 article-title: Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias publication-title: Mol. Cancer Ther. contributor: fullname: McQueen – volume: 103 start-page: 620 year: 1985 end-page: 625 ident: bib0075 article-title: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group publication-title: Ann. Intern. Med. contributor: fullname: Sultan – volume: 461 start-page: 123 year: 2019 end-page: 131 ident: bib0660 article-title: Notch signaling in breast cancer: from pathway analysis to therapy publication-title: Cancer Lett. contributor: fullname: Singhal – volume: 143 start-page: 367 year: 2016 end-page: 372 ident: bib0705 article-title: Hedgehog signalling publication-title: Development contributor: fullname: Ingham – volume: 3 start-page: 3261 year: 2019 end-page: 3265 ident: bib0150 article-title: Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells publication-title: Blood Adv. contributor: fullname: Guzman – volume: 441 start-page: 475 year: 2006 end-page: 482 ident: bib1295 article-title: Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells publication-title: Nature contributor: fullname: Morrison – volume: 38 start-page: 430 year: 2014 end-page: 434 ident: bib0260 article-title: A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia publication-title: Leuk. Res. contributor: fullname: Stone – volume: 307 start-page: 1098 year: 2005 end-page: 1101 ident: bib1015 article-title: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex publication-title: Science contributor: fullname: Sabatini – volume: 577 start-page: 266 year: 2020 end-page: 270 ident: bib0765 article-title: HBO1 is required for the maintenance of leukaemia stem cells publication-title: Nature contributor: fullname: Yeung – volume: 119 start-page: 5492 year: 2012 end-page: 5501 ident: bib0885 article-title: Cyclin-A1 represents a new targetable immunogenic antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer testicular antigen publication-title: Blood contributor: fullname: Schmitt – volume: 22 start-page: 2454 year: 2008 end-page: 2472 ident: bib1205 article-title: Hedgehog: functions and mechanisms publication-title: Genes Dev. contributor: fullname: Taipale – volume: 76 start-page: 1417 year: 2008 end-page: 1425 ident: bib0110 article-title: Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison publication-title: Biochem. Pharmacol. contributor: fullname: Kroemer – volume: 35 start-page: 127 year: 2002 end-page: 137 ident: bib1070 article-title: Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells publication-title: Mol. Carcinog. contributor: fullname: Konishi – volume: 58 start-page: 65 year: 2019 end-page: 79 ident: bib0315 article-title: Overview of the oncogenic signaling pathways in colorectal cancer: mechanistic insights publication-title: Semin. Cancer Biol. contributor: fullname: Siddik – volume: 17 start-page: 13 year: 2010 end-page: 27 ident: bib0325 article-title: DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia publication-title: Cancer Cell contributor: fullname: Melnick – volume: 8 start-page: 482 year: 2019 ident: bib0905 article-title: 7-ketocholesterol promotes oxiapoptophagy in bone marrow mesenchymal stem cell from patients with acute myeloid leukemia publication-title: Cells contributor: fullname: Bydlowski – volume: 288 start-page: 33542 year: 2013 end-page: 33558 ident: bib0910 article-title: Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells publication-title: J. Biol. Chem. contributor: fullname: Jordan – volume: 128 start-page: 5479 year: 2018 end-page: 5488 ident: bib1055 article-title: Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells publication-title: J. Clin. Invest. contributor: fullname: Verma – volume: 369 start-page: 20 year: 2015 end-page: 27 ident: bib1315 article-title: Notch signaling: an emerging therapeutic target for cancer treatment publication-title: Cancer Lett. contributor: fullname: Wu – volume: 2 start-page: e339 year: 2015 end-page: e346 ident: bib0805 article-title: Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study publication-title: Lancet Haematol. contributor: fullname: Jamieson – volume: 124 start-page: 528 year: 2014 end-page: 542 ident: bib0600 article-title: Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity publication-title: J. Clin. Invest. contributor: fullname: Kurokawa – volume: 119 start-page: 5492 issue: 23 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0885 article-title: Cyclin-A1 represents a new targetable immunogenic antigen expressed in acute myeloid leukemia stem cells with characteristics of a cancer testicular antigen publication-title: Blood doi: 10.1182/blood-2011-07-365890 contributor: fullname: Ochsenreither – volume: 29 start-page: 1267 issue: 6 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0330 article-title: Pre-clinical efficacy of combined therapy with novel β-catenin antagonist BC2059 and histone deacetylase inhibitor against AML cells publication-title: Leukemia doi: 10.1038/leu.2014.340 contributor: fullname: Fiskus – volume: 13 start-page: 449 issue: 3 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0015 article-title: MUC1-C induces the LIN28B→LET-7→HMGA2 Axis to regulate self-renewal in NSCLC publication-title: Mol. Cancer Res. MCR doi: 10.1158/1541-7786.MCR-14-0363 contributor: fullname: Alam – volume: 33 start-page: 451 issue: August (4) year: 1976 ident: 10.1016/j.critrevonc.2021.103277_bib0070 article-title: Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.1976.tb03563.x contributor: fullname: Bennett – volume: 7 start-page: 397 issue: 4 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib0855 article-title: PPAR trilogy from metabolism to cancer publication-title: Curr. Opin. Clin. Nutr. Metab. Care doi: 10.1097/01.mco.0000134360.30911.bb contributor: fullname: Nahlé – volume: 2 start-page: 47 issue: 1 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib1240 article-title: The TGFbeta superfamily signaling pathway. Wiley interdisciplinary reviews publication-title: Dev. Biol. contributor: fullname: Weiss – volume: 60 start-page: 1085 issue: 8 year: 2000 ident: 10.1016/j.critrevonc.2021.103277_bib0120 article-title: Nuclear factor-kappa B, cancer, and apoptosis publication-title: Biochem. Pharmacol. doi: 10.1016/S0006-2952(00)00391-9 contributor: fullname: Bours – volume: 58 start-page: 65 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0315 article-title: Overview of the oncogenic signaling pathways in colorectal cancer: mechanistic insights publication-title: Semin. Cancer Biol. doi: 10.1016/j.semcancer.2019.01.001 contributor: fullname: Farooqi – volume: 127 start-page: 1202 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0285 article-title: Distinct but complementary contributions of PPAR isotypes to energy homeostasis publication-title: J. Clin. Invest. doi: 10.1172/JCI88894 contributor: fullname: Dubois – volume: 23 start-page: 3385 issue: 13 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0460 article-title: Antileukemia efficacy and mechanisms of action of SL-101, a novel Anti-CD123 antibody conjugate, in acute myeloid leukemia publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-16-1904 contributor: fullname: Han – volume: 103 start-page: 620 issue: October (4) year: 1985 ident: 10.1016/j.critrevonc.2021.103277_bib0075 article-title: Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-103-4-620 contributor: fullname: Bennett – volume: 29 start-page: 214 issue: 2 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0700 article-title: miR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cells publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.12.011 contributor: fullname: Lechman – year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0960 article-title: Targeting CD70 with cusatuzumab eliminates acute myeloid leukemia stem cells in patients treated with hypomethylating agents publication-title: Nat. Med. doi: 10.1038/s41591-020-0910-8 contributor: fullname: Riether – volume: 106 start-page: djt440 issue: 2 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0170 article-title: Synergistic targeting of AML stem/progenitor cells with IAP antagonist birinapant and demethylating agents publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djt440 contributor: fullname: Carter – volume: 2 start-page: e339 issue: 8 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0805 article-title: Treatment with PF-04449913, an oral smoothened antagonist, in patients with myeloid malignancies: a phase 1 safety and pharmacokinetics study publication-title: Lancet Haematol. doi: 10.1016/S2352-3026(15)00096-4 contributor: fullname: Martinelli – volume: 6 start-page: 377 issue: 5 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib1245 article-title: Mechanism of fenretinide (4-HPR)-induced cell death publication-title: Apoptosis: Int. J. Programmed Cell Death doi: 10.1023/A:1011342220621 contributor: fullname: Wu – volume: 9 start-page: e96698 issue: 5 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0565 article-title: The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin-induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells publication-title: PLoS One doi: 10.1371/journal.pone.0096698 contributor: fullname: Jiang – volume: 104 start-page: 2006 issue: 10 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0200 article-title: Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells publication-title: Haematologica doi: 10.3324/haematol.2018.192062 contributor: fullname: Chapellier – volume: 19 start-page: 1738 issue: 6 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0145 article-title: Functional regulation of PPARs through post-translational modifications publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms19061738 contributor: fullname: Brunmeir – volume: 1 start-page: 13 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib1345 article-title: Reactive oxygen species in eradicating acute myeloid leukemic stem cells publication-title: Stem Cell Investig. contributor: fullname: Zhang – volume: 32 start-page: 1550 issue: 10 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0490 article-title: Arsenic disulfide synergizes with the phosphoinositide 3-kinase inhibitor PI-103 to eradicate acute myeloid leukemia stem cells by inducing differentiation publication-title: Carcinogenesis doi: 10.1093/carcin/bgr176 contributor: fullname: Hong – volume: 441 start-page: 431 issue: 7092 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0615 article-title: Nuclear factor-kappaB in cancer development and progression publication-title: Nature doi: 10.1038/nature04870 contributor: fullname: Karin – volume: 7 start-page: 33004 issue: 22 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0715 article-title: Gli-1/PI3K/AKT/NF-kB pathway mediates resistance to radiation and is a target for reversion of responses in refractory acute myeloid leukemia cells publication-title: Oncotarget doi: 10.18632/oncotarget.8844 contributor: fullname: Li – volume: 483656 issue: 2012 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib1115 article-title: Effects of PPARγ ligands on leukemia publication-title: PPAR Res. contributor: fullname: Tabe – volume: 35 start-page: 6045 issue: 47 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0785 article-title: Targeting CK2-driven non-oncogene addiction in B-cell tumors publication-title: Oncogene doi: 10.1038/onc.2016.86 contributor: fullname: Mandato – volume: 41 start-page: 858 issue: 10 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0125 article-title: Nonhematopoietic cells represent a more rational target of in vivo hedgehog signaling affecting normal or acute myeloid leukemia progenitors publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2013.05.287 contributor: fullname: Boyd – volume: 8 issue: 6 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0010 article-title: Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia publication-title: PLoS Genet. doi: 10.1371/journal.pgen.1002781 contributor: fullname: Akalin – volume: 17 start-page: 13 issue: 1 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0325 article-title: DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.11.020 contributor: fullname: Figueroa – volume: 164 start-page: 481 issue: 4 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0365 article-title: Antibody therapy for acute myeloid leukaemia publication-title: Br. J. Haematol. doi: 10.1111/bjh.12691 contributor: fullname: Gasiorowski – volume: 16 start-page: 27 issue: 1 year: 2000 ident: 10.1016/j.critrevonc.2021.103277_bib0900 article-title: TGF beta-related pathways. Roles in Caenorhabditis elegans development publication-title: Trends Genetics: TIG doi: 10.1016/S0168-9525(99)01916-2 contributor: fullname: Patterson – volume: 6 start-page: 5490 issue: 8 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib1365 article-title: Aberrant nuclear factor-kappa B activity in acute myeloid leukemia: from molecular pathogenesis to therapeutic target publication-title: Oncotarget doi: 10.18632/oncotarget.3545 contributor: fullname: Zhou – volume: 8 start-page: 482 issue: 5 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0905 article-title: 7-ketocholesterol promotes oxiapoptophagy in bone marrow mesenchymal stem cell from patients with acute myeloid leukemia publication-title: Cells doi: 10.3390/cells8050482 contributor: fullname: Paz – volume: 10 start-page: 457 issue: 3 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0750 article-title: Two TOR complexes, only one of which is rapamycin sensitive, have distinct roles in cell growth control publication-title: Mol. Cell doi: 10.1016/S1097-2765(02)00636-6 contributor: fullname: Loewith – volume: 14 start-page: 2009 issue: 19 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0795 article-title: Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin module for acute myelogenous leukemia therapy: from bench to bedside publication-title: Curr. Med. Chem. doi: 10.2174/092986707781368423 contributor: fullname: Martelli – volume: 1443 start-page: 54 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0380 article-title: The Wnt signaling pathway: a potential therapeutic target against cancer publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/nyas.14027 contributor: fullname: Ghosh – volume: 114 start-page: 1498 issue: 8 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0970 article-title: Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis publication-title: Blood doi: 10.1182/blood-2009-03-209734 contributor: fullname: Rizo – volume: 114 start-page: 937 issue: July 30 (5) year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib1200 article-title: The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes publication-title: Blood doi: 10.1182/blood-2009-03-209262 contributor: fullname: Vardiman – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0135 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21492 contributor: fullname: Bray – volume: 8 start-page: 627 issue: 8 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0735 article-title: Targeting the phosphoinositide 3-kinase pathway in cancer publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2926 contributor: fullname: Liu – volume: 97 start-page: 2177 issue: 7 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0430 article-title: Expression of tumor-suppressor genes interferon regulatory factor 1 and death-associated protein kinase in primitive acute myelogenous leukemia cells publication-title: Blood doi: 10.1182/blood.V97.7.2177 contributor: fullname: Guzman – volume: 77 start-page: 7103 issue: 16 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib1335 article-title: Biomimetic semisynthesis of arglabin from parthenolide publication-title: J. Org. Chem. doi: 10.1021/jo300888s contributor: fullname: Zhai – volume: 16 start-page: 797 issue: 8 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0845 article-title: PI3K/Akt/mTOR pathway as a target for cancer therapy publication-title: Anticancer Drugs doi: 10.1097/01.cad.0000173476.67239.3b contributor: fullname: Morgensztern – volume: 278 start-page: 49530 issue: 49 year: 2003 ident: 10.1016/j.critrevonc.2021.103277_bib0045 article-title: Isoform-specific regulation of insulin-dependent glucose uptake by Akt/protein kinase B publication-title: J. Biol. Chem. doi: 10.1074/jbc.M306782200 contributor: fullname: Bae – volume: 91 start-page: 757 issue: 6 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0060 article-title: Single cell analysis of phosphoinositide 3-kinase/Akt and ERK activation in acute myeloid leukemia by flow cytometry publication-title: Haematologica contributor: fullname: Bardet – volume: 12 start-page: 548 issue: 6 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0820 article-title: Biology and therapeutic applications of peroxisome proliferator- activated receptors publication-title: Curr. Top. Med. Chem. doi: 10.2174/156802612799436669 contributor: fullname: Menendez-Gutierrez – volume: 459 start-page: 692 issue: 4 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0520 article-title: Phosphoinositide-dependent kinase 1 regulates leukemia stem cell maintenance in MLL-AF9-induced murine acute myeloid leukemia publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2015.03.007 contributor: fullname: Hu – volume: 8 start-page: 8420 issue: 5 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0720 article-title: Sensitizing leukemia stem cells to NF-κB inhibitor treatment in vivo by inactivation of both TNF and IL-1 signaling publication-title: Oncotarget doi: 10.18632/oncotarget.14220 contributor: fullname: Li – volume: 410 start-page: 1 issue: 1 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0040 article-title: The regulation and function of Class III PI3Ks: novel roles for Vps34 publication-title: Biochem. J. doi: 10.1042/BJ20071427 contributor: fullname: Backer – volume: 9 start-page: eaaj2025 issue: 374 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0235 article-title: CD99 is a therapeutic target on disease stem cells in myeloid malignancies publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaj2025 contributor: fullname: Chung – volume: 3 start-page: 1249 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib0655 article-title: Peroxisome proliferator-activated receptor γ and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.1249.3.10 contributor: fullname: Konopleva – volume: 3 start-page: 651 issue: 9 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0710 article-title: Stats: transcriptional control and biological impact publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm909 contributor: fullname: Levy – volume: 441 start-page: 475 issue: 7092 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib1295 article-title: Pten dependence distinguishes haematopoietic stem cells from leukaemia-initiating cells publication-title: Nature doi: 10.1038/nature04703 contributor: fullname: Yilmaz – volume: 142 start-page: 164 issue: 2 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0935 article-title: Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2013.12.004 contributor: fullname: Polivka – volume: 97 start-page: 966 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0500 article-title: Recent advances in acute myeloid leukemia stem cell biology publication-title: Haematologica doi: 10.3324/haematol.2011.054734 contributor: fullname: Horton – volume: 27 start-page: 6473 issue: 50 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0335 article-title: PI3K/Akt: getting it right matters publication-title: Oncogene doi: 10.1038/onc.2008.313 contributor: fullname: Franke – volume: 10 start-page: 215 issue: 3 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0375 article-title: Essential role of tuberous sclerosis genes TSC1 and TSC2 in NF-kappaB activation and cell survival publication-title: Cancer Cell doi: 10.1016/j.ccr.2006.08.007 contributor: fullname: Ghosh – volume: 22 start-page: 350 issue: 2 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1250 article-title: Stabilization of NF-κB-Inducing kinase suppresses MLL-AF9-Induced acute myeloid leukemia publication-title: Cell Rep. doi: 10.1016/j.celrep.2017.12.055 contributor: fullname: Xiu – volume: 12 start-page: 72 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1095 article-title: Nuclear factor of activated T-cells, NFATC1, governs FLT3ITD-driven hematopoietic stem cell transformation and a poor prognosis in AML publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-019-0765-y contributor: fullname: Solovey – volume: 42 start-page: S20 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0230 article-title: CD99 is a therapeutic target on disease stem cells in acute myeloid leukemia and the myelodysplastic syndromes publication-title: Exp. Hematol. doi: 10.1016/j.exphem.2014.07.071 contributor: fullname: Chung – volume: 107 start-page: 1156 issue: 3 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0130 article-title: NF-kappaB constitutes a potential therapeutic target in high-risk myelodysplastic syndrome publication-title: Blood doi: 10.1182/blood-2005-05-1989 contributor: fullname: Braun – volume: 115 start-page: 279 issue: 2 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0865 article-title: Analysis of expression of nuclear factor kappa B (NF-kappa B) in multiple myeloma: downregulation of NF-kappa B induces apoptosis publication-title: Br. J. Haematol. doi: 10.1046/j.1365-2141.2001.03102.x contributor: fullname: Ni – start-page: 1083 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib1325 article-title: Notch and its ligands contributor: fullname: Zanotti – volume: 106 start-page: 3396 issue: 9 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0780 article-title: Dysregulated gene expression networks in human acute myelogenous leukemia stem cells publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0900089106 contributor: fullname: Majeti – volume: 8 start-page: 29187 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0690 article-title: Combined inhibition of GLI and FLT3 signaling leads to effective anti-leukemic effects in human acute myeloid leukemia publication-title: Oncotarget doi: 10.18632/oncotarget.16304 contributor: fullname: Latuske – volume: 106 start-page: 4261 issue: 13 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib1260 article-title: mTOR regulates cell survival after etoposide treatment in primary AML cells publication-title: Blood doi: 10.1182/blood-2004-11-4468 contributor: fullname: Xu – volume: 48 start-page: 453 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0100 article-title: Overview of the therapeutic potential of piplartine (piperlongumine) publication-title: Eur. J. Pharm. Sci. doi: 10.1016/j.ejps.2012.12.003 contributor: fullname: Bezerra – volume: 109 start-page: 15115 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0005 article-title: Synthesis, cellular evaluation, and mechanism of action of piperlongumine analogs publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1212802109 contributor: fullname: Adams – volume: 514 start-page: 1278 issue: 4 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0610 article-title: Cancer upregulated gene 2 (CUG2), a novel oncogene, promotes stemness-like properties via the NPM1-TGF-β signaling axis publication-title: Biochem. Biophys. Res. Commun. doi: 10.1016/j.bbrc.2019.05.091 contributor: fullname: Kaowinn – volume: 1 start-page: 8 issue: 1 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0670 article-title: Novel insights into the differential functions of Notch ligands in vascular formation publication-title: J. Angiogenes. Res. doi: 10.1186/2040-2384-1-8 contributor: fullname: Kume – volume: 210 start-page: 321 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0605 article-title: Notch activation inhibits AML growth and survival: a potential therapeutic approach publication-title: J. Exp. Med. doi: 10.1084/jem.20121527 contributor: fullname: Kannan – volume: 38 start-page: 687 issue: 5 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0695 article-title: Hedgehog/GLI1 activation leads to leukemic transformation of myelodysplastic syndrome in vivo and GLI1 inhibition results in antitumor activity publication-title: Oncogene doi: 10.1038/s41388-018-0431-9 contributor: fullname: Lau – volume: 6 start-page: 25476 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0540 article-title: Deregulated hedgehog pathway signaling is inhibited by the smoothened antagonist LDE225 (Sonidegib) in chronic phase chronic myeloid leukaemia publication-title: Sci. Rep. doi: 10.1038/srep25476 contributor: fullname: Irvine – volume: 5 start-page: 4337 issue: 12 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0840 article-title: XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells publication-title: Oncotarget doi: 10.18632/oncotarget.2016 contributor: fullname: Moreno-Martínez – volume: 8 start-page: 104367 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0250 article-title: Novel piplartine-containing ruthenium complexes: synthesis, cell growth inhibition, apoptosis induction and ROS production on HCT116 cells publication-title: Oncotarget doi: 10.18632/oncotarget.22248 contributor: fullname: Costa – volume: 95 start-page: 71 issue: 1 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib1355 article-title: Targeting C-type lectin-like molecule-1 for antibody-mediated immunotherapy in acute myeloid leukemia publication-title: Haematologica doi: 10.3324/haematol.2009.009811 contributor: fullname: Zhao – volume: 19 start-page: 717 issue: 8 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1050 article-title: Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia publication-title: Expert Rev. Anticancer Ther. doi: 10.1080/14737140.2019.1652095 contributor: fullname: Shallis – volume: 4 start-page: 281 issue: 4–5 year: 1995 ident: 10.1016/j.critrevonc.2021.103277_bib0390 article-title: Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping publication-title: Gene Expr. contributor: fullname: Greene – volume: 288 start-page: 33542 issue: 47 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0910 article-title: Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M113.511170 contributor: fullname: Pei – volume: 17 start-page: 53 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0740 article-title: EGFR-TKIs resistance via EGFR-independent signaling pathways publication-title: Mol. Cancer doi: 10.1186/s12943-018-0793-1 contributor: fullname: Liu – volume: 26 start-page: 1631 issue: 7 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib1155 article-title: Evolutionary scenarios of Notch proteins publication-title: Mol. Biol. Evol. doi: 10.1093/molbev/msp075 contributor: fullname: Theodosiou – volume: 98 start-page: 2301 issue: 8 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0425 article-title: Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells publication-title: Blood doi: 10.1182/blood.V98.8.2301 contributor: fullname: Guzman – volume: 39 start-page: 830 issue: 10 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0195 article-title: Canonical and non-canonical wnt signaling in immune cells publication-title: Trends Immunol. doi: 10.1016/j.it.2018.08.006 contributor: fullname: Chae – volume: 70 start-page: 2516 issue: 6 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0580 article-title: Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-3950 contributor: fullname: Jin – volume: 29 start-page: 437 issue: 2 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0990 article-title: Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells publication-title: Int. J. Oncol. contributor: fullname: Saiki – year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0555 contributor: fullname: Jaffe – volume: 511 start-page: 90 issue: 7507 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib1320 article-title: The sonic hedgehog factor GLI1 imparts drug resistance through inducible glucuronidation publication-title: Nature doi: 10.1038/nature13283 contributor: fullname: Zahreddine – volume: 29 start-page: 233 issue: 5 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib0140 article-title: Advances in protein kinase B signalling: AKTion on multiple fronts publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2004.03.006 contributor: fullname: Brazil – volume: 15 start-page: 294 issue: 3 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib1370 article-title: LIN28B activation by PRL-3 promotes leukemogenesis and a stem cell-like transcriptional program in AML publication-title: Mol. Cancer Res. MCR doi: 10.1158/1541-7786.MCR-16-0275-T contributor: fullname: Zhou – volume: 100 start-page: 948 issue: 5 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0640 article-title: Drug resistance is dramatically restored by hedgehog inhibitors in CD34+ leukemic cells publication-title: Cancer Sci. doi: 10.1111/j.1349-7006.2009.01111.x contributor: fullname: Kobune – volume: 7 start-page: 61 issue: 9 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0975 article-title: Telomerase activation in hematological malignancies publication-title: Genes (Basel). doi: 10.3390/genes7090061 contributor: fullname: Ropio – volume: 25 start-page: 203 issue: 1 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0190 article-title: Notch signaling induces apoptosis in primary human CD34+ hematopoietic progenitor cells publication-title: Stem cells (Dayton, Ohio) doi: 10.1634/stemcells.2005-0303 contributor: fullname: Chadwick – volume: 19 start-page: 2783 issue: 23 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0810 article-title: Smad transcription factors publication-title: Genes Dev. doi: 10.1101/gad.1350705 contributor: fullname: Massagué – volume: 99 start-page: 16220 issue: 25 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0435 article-title: Preferential induction of apoptosis for primary human leukemic stem cells publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.252462599 contributor: fullname: Guzman – volume: 12 start-page: eaaz8264 issue: 538 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0830 article-title: The mitochondrial peptidase, neurolysin, regulates respiratory chain supercomplex formation and is necessary for AML viability publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaz8264 contributor: fullname: Mirali – volume: 133 start-page: 1967 issue: 8 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib1280 article-title: IL-1β inhibits self-renewal capacity of dormant CD34+/CD38− acute myelogenous leukemia cells in vitro and in vivo publication-title: Int. J. Cancer doi: 10.1002/ijc.28198 contributor: fullname: Yang – volume: 123 start-page: 2826 issue: 18 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0245 article-title: Role of altered growth factor receptor-mediated JAK2 signaling in growth and maintenance of human acute myeloid leukemia stem cells publication-title: Blood doi: 10.1182/blood-2013-05-505735 contributor: fullname: Cook – volume: 99 start-page: 141 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0290 article-title: The Wnt signaling pathway in cancer publication-title: Crit. Rev. Oncol. Hematol. doi: 10.1016/j.critrevonc.2015.12.005 contributor: fullname: Duchartre – volume: 6 start-page: 91 issue: 1 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib1060 article-title: The LKB1 tumor suppressor negatively regulates mTOR signaling publication-title: Cancer Cell doi: 10.1016/j.ccr.2004.06.007 contributor: fullname: Shaw – volume: 20 start-page: 13 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0590 article-title: The leukemic stem cell publication-title: Best Pract. Res. Clin. Haematol. doi: 10.1016/j.beha.2006.10.005 contributor: fullname: Jordan – volume: 78 start-page: 325 issue: July (3) year: 1991 ident: 10.1016/j.critrevonc.2021.103277_bib0085 article-title: Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) publication-title: Br. J. Haematol. doi: 10.1111/j.1365-2141.1991.tb04444.x contributor: fullname: Bennett – volume: 7 start-page: 55083 issue: 34 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib1330 article-title: MLN0128, a novel mTOR kinase inhibitor, disrupts survival signaling and triggers apoptosis in AML and AML stem/ progenitor cells publication-title: Oncotarget doi: 10.18632/oncotarget.10397 contributor: fullname: Zeng – volume: 20 start-page: 2147 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0350 article-title: Perfis de expressão genética de células-tronco derivadas da LMA; semelhança com células-tronco hematopoiéticas publication-title: Leucemia contributor: fullname: Gal – volume: 54 start-page: 955 issue: 6–7 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0180 article-title: Novel roles for Notch, Wnt and Hedgehog in hematopoesis derived from human pluripotent stem cells publication-title: Int. J. Dev. Biol. doi: 10.1387/ijdb.103067cc contributor: fullname: Cerdan – volume: 1799 start-page: 775 issue: 10–12 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0420 article-title: Inhibiting NF-κB activation by small molecules as a therapeutic strategy publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbagrm.2010.05.004 contributor: fullname: Gupta – volume: 109 start-page: S121 issue: Suppl year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0880 article-title: Cytokine signaling in 2002: new surprises in the Jak/Stat pathway publication-title: Cell doi: 10.1016/S0092-8674(02)00701-8 contributor: fullname: O’Shea – volume: 94 start-page: 950 issue: 9 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib1210 article-title: Micheliolide, a new sesquiterpene lactone that inhibits intestinal inflammation and colitis-associated cancer publication-title: Lab. Invest. doi: 10.1038/labinvest.2014.89 contributor: fullname: Viennois – volume: 75 start-page: 1343 issue: 4 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib1235 article-title: Dual phosphoproteomics and chemical proteomics analysis of erlotinib and gefitinib interference in acute myeloid leukemia cells publication-title: J. Proteomics doi: 10.1016/j.jprot.2011.11.004 contributor: fullname: Weber – volume: 8 start-page: 22 issue: 2 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0965 article-title: Targeting the sonic hedgehog signaling pathway: review of smoothened and GLI inhibitors publication-title: Cancers doi: 10.3390/cancers8020022 contributor: fullname: Rimkus – volume: 2 start-page: 16042 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0020 article-title: The paradoxical functions of EGFR during breast cancer progression publication-title: Signal Transduct. Target. Ther. doi: 10.1038/sigtrans.2016.42 contributor: fullname: Ali – volume: 461 start-page: 123 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0660 article-title: Notch signaling in breast cancer: from pathway analysis to therapy publication-title: Cancer Lett. doi: 10.1016/j.canlet.2019.07.012 contributor: fullname: Krishna – volume: 7 start-page: 1554 issue: 3 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0240 article-title: Hedgehog signaling in the maintenance of cancer stem cells publication-title: Cancers doi: 10.3390/cancers7030851 contributor: fullname: Cochrane – volume: 98 start-page: 627 issue: 6 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0620 article-title: TIM-3 as a novel therapeutic target for eradicating acute myelogenous leukemia stem cells publication-title: Int. J. Hematol. doi: 10.1007/s12185-013-1433-6 contributor: fullname: Kikushige – volume: 34 start-page: 1027 issue: 4 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0320 article-title: Differences in expression and function of LEF1 isoforms in normal versus leukemic hematopoiesis publication-title: Leukemia doi: 10.1038/s41375-019-0635-1 contributor: fullname: Feder – volume: 1 start-page: 20 issue: 1 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0835 article-title: First-in-class, first-in-human phase I results of targeted agents: highlights of the 2008 American society of clinical oncology meeting publication-title: J. Hematol. Oncol. doi: 10.1186/1756-8722-1-20 contributor: fullname: Molckovsky – volume: 32 start-page: 1313 issue: 5 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0495 article-title: Molecular integration of HoxB4 and STAT3 for self-renewal of hematopoietic stem cells: a model of molecular convergence for stemness publication-title: Stem Cells (Dayton, Ohio) doi: 10.1002/stem.1631 contributor: fullname: Hong – volume: 34 start-page: 724 issue: 5 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0585 article-title: Inhibition of amino acid metabolism selectively targets human leukemia stem cells publication-title: Cancer Cell doi: 10.1016/j.ccell.2018.10.005 contributor: fullname: Jones – volume: 103 start-page: 460 issue: September (3) year: 1985 ident: 10.1016/j.critrevonc.2021.103277_bib0080 article-title: Criteria for the diagnosis of acute leukemia of megakaryocyte lineage (M7). A report of the French-American-British Cooperative Group publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-103-3-460 contributor: fullname: Bennett – volume: 3 start-page: 24 issue: 1 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0025 article-title: Hedgehog–Gli signaling and the growth of the-brain publication-title: Nat. Rev. Neurosci. doi: 10.1038/nrn704 contributor: fullname: Altaba – volume: 19 start-page: 586 issue: 4 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0385 article-title: PI3-kinase/Akt is constitutively active in primary acute myeloid leukaemia cells and regulates survival and chemoresistance via NF-kappaB, Mapkinase and p53 pathways publication-title: Leukemia doi: 10.1038/sj.leu.2403653 contributor: fullname: Grandage – volume: 25 start-page: 903 issue: 6 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib1005 article-title: PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase publication-title: Mol. Cell doi: 10.1016/j.molcel.2007.03.003 contributor: fullname: Sancak – volume: 12 start-page: 1167 issue: 10 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0575 article-title: Targeting of CD44 eradicates human acute myeloid leukemic stem cells publication-title: Nat. Med. doi: 10.1038/nm1483 contributor: fullname: Jin – volume: 315 start-page: 3004 issue: 17 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib1010 article-title: Identification of multipotent mesenchymal stromal cells in the reactive stroma of a prostate cancer xenograft by side population analysis publication-title: Exp. Cell Res. doi: 10.1016/j.yexcr.2009.05.007 contributor: fullname: Santamaria-Martínez – volume: 6 start-page: 1 issue: 1 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0355 article-title: Notch signal strength controls cell fate in the haemogenic endothelium publication-title: Nat. Commun. doi: 10.1038/ncomms9510 contributor: fullname: Gama-Norton – volume: 13 start-page: 2422 issue: 10 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0455 article-title: Piperlongumine chemosensitizes tumor cells through interaction with cysteine 179 of IκBα kinase, leading to suppression of NF-κB-regulated gene products publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-14-0171 contributor: fullname: Han – volume: 2 start-page: 17ra9 issue: 17 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0995 article-title: Identification of therapeutic targets for quiescent, chemotherapy-resistant human leukemia stem cells publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3000349 contributor: fullname: Saito – volume: 39 start-page: 897 issue: 8 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib1140 article-title: STAT5A regulates DNMT3A in CD34(+)/CD38(-) AML cells publication-title: Leuk. Res. doi: 10.1016/j.leukres.2015.05.006 contributor: fullname: Takeuchi – volume: 27 start-page: 5497 issue: 41 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib1310 article-title: PI3K pathway alterations in cancer: variations on a theme publication-title: Oncogene doi: 10.1038/onc.2008.245 contributor: fullname: Yuan – volume: 1 start-page: 5 issue: 1 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0345 article-title: Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical application publication-title: Biomark. Res. doi: 10.1186/2050-7771-1-5 contributor: fullname: Furqan – volume: 7 start-page: 208 issue: 11 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1020 article-title: Hedgehog signaling in cancer: a prospective therapeutic target for eradicating Cancer stem cells publication-title: Cells doi: 10.3390/cells7110208 contributor: fullname: Sari – volume: 16 start-page: 13 issue: 1 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib1085 article-title: Targeting acute myeloid leukemia stem cell signaling by natural products publication-title: Mol. Cancer doi: 10.1186/s12943-016-0571-x contributor: fullname: Siveen – volume: 33 start-page: 2379 issue: 10 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0955 article-title: CD8+ T cells expand stem and progenitor cells in favorable but not adverse risk acute myeloid leukemia publication-title: Leukemia doi: 10.1038/s41375-019-0441-9 contributor: fullname: Radpour – volume: 19 start-page: 1933 issue: 8 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0950 article-title: Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-12-0284 contributor: fullname: Quintás-Cardama – volume: 13 start-page: 98 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0985 article-title: GLI2 inhibition abrogates human leukemia stem cell dormancy publication-title: J. Transl. Med. doi: 10.1186/s12967-015-0453-9 contributor: fullname: Sadarangani – volume: 25 start-page: 496 issue: 10 year: 2000 ident: 10.1016/j.critrevonc.2021.103277_bib0505 article-title: STAT proteins and transcriptional responses to extracellular signals publication-title: Trends Biochem. Sci. doi: 10.1016/S0968-0004(00)01624-8 contributor: fullname: Horvath – volume: 19 start-page: 717 issue: 8 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0980 article-title: Hedgehog pathway inhibition as a therapeutic target in acute myeloid leukemia publication-title: Expert Rev. Anticancer Ther. doi: 10.1080/14737140.2019.1652095 contributor: fullname: Rory – volume: 4 start-page: 68 issue: 2 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0650 article-title: Wnt signal transduction pathways publication-title: Organogenesis doi: 10.4161/org.4.2.5851 contributor: fullname: Komiya – volume: 35 start-page: 127 issue: 3 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib1070 article-title: Contributions of mitogen-activated protein kinase and nuclear factor kappa B to N-(4-hydroxyphenyl)retinamide-induced apoptosis in prostate cancer cells publication-title: Mol. Carcinog. doi: 10.1002/mc.10084 contributor: fullname: Shimada – volume: 76 start-page: 1417 issue: 11 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0110 article-title: Erlotinib and gefitinib for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a preclinical comparison publication-title: Biochem. Pharmacol. doi: 10.1016/j.bcp.2008.05.024 contributor: fullname: Boehrer – volume: 57 start-page: 17 issue: Suppl 2 year: 1999 ident: 10.1016/j.critrevonc.2021.103277_bib0485 article-title: Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60 publication-title: Oncology doi: 10.1159/000055271 contributor: fullname: Hirase – volume: 5 start-page: 15646 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0760 article-title: SKLB-677, an FLT3 and Wnt/β-catenin signaling inhibitor, displays potent activity in models of FLT3-driven AML publication-title: Sci. Rep. doi: 10.1038/srep15646 contributor: fullname: Ma – volume: 118 start-page: 2830 issue: 10 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1360 article-title: The histone methyltransferase inhibitor, DZNep, up-regulates TXNIP, increases ROS production, and targets leukemia cells in AML publication-title: Blood doi: 10.1182/blood-2010-07-294827 contributor: fullname: Zhou – volume: 31 start-page: 292 issue: 2 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib1185 article-title: Protein kinase CK2 regulates AKT, NF-κB and STAT3 activation, stem cell viability and proliferation in acute myeloid leukemia publication-title: Leukemia doi: 10.1038/leu.2016.209 contributor: fullname: Tubi – volume: 122 start-page: 2114 issue: 6 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0515 article-title: mTORC1 is essential for leukemia propagation but not stem cell self-renewal publication-title: J. Clin. Invest. doi: 10.1172/JCI62279 contributor: fullname: Hoshii – start-page: 103 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0115 article-title: Targeting the hedgehog and notch signaling pathways in cancer stem cells contributor: fullname: Borah – volume: 34 start-page: 115 issue: 3 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0645 article-title: Regulation of phosphoinositide 3-kinase expression in health and disease publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2009.01.003 contributor: fullname: Kok – volume: 108 start-page: 1208 issue: 4 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0225 article-title: Unique effects of Stat3 on the early phase of hematopoietic stem cell regeneration publication-title: Blood doi: 10.1182/blood-2006-01-010199 contributor: fullname: Chung – volume: 7 start-page: 38974 issue: 26 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib1120 article-title: MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia publication-title: Oncotarget doi: 10.18632/oncotarget.9777 contributor: fullname: Tagde – volume: 21 start-page: 1638 issue: 8 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0825 article-title: The emerging role of Wnt signaling in the pathogenesis of acute myeloid leukemia publication-title: Leukemia doi: 10.1038/sj.leu.2404732 contributor: fullname: Mikesch – volume: 30 start-page: 1 issue: 1 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib1125 article-title: Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present) publication-title: Expert Opin. Ther. Pat. doi: 10.1080/13543776.2020.1703952 contributor: fullname: Takada – volume: 16 start-page: 1134 issue: 14 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib1080 article-title: Review on EGFR inhibitors: critical updates publication-title: Mini Rev. Med. Chem. doi: 10.2174/1389557516666160321114917 contributor: fullname: Singh – volume: 8 start-page: 114 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib1160 article-title: The Hedgehog pathway as targetable vulnerability with 5-azacytidine in myelodysplastic syndrome and acute myeloid leukemia publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-015-0211-8 contributor: fullname: Tibes – volume: 9 start-page: 24 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0930 article-title: NF-kappaB: two sides of the same coin publication-title: Genes doi: 10.3390/genes9010024 contributor: fullname: Pires – volume: 210 start-page: 301 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0745 article-title: Notch pathway activation targets AML-initiating cell homeostasis and differentiation publication-title: J. Exp. Med. doi: 10.1084/jem.20121484 contributor: fullname: Lobry – year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0310 article-title: Epidermal growth factor receptor-dependent DNA repair promotes murine and human hematopoietic regeneration publication-title: Blood doi: 10.1182/blood.2020005895 contributor: fullname: Fang – volume: 38 start-page: 430 issue: 4 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0260 article-title: A phase II study of the EGFR inhibitor gefitinib in patients with acute myeloid leukemia publication-title: Leuk. Res. doi: 10.1016/j.leukres.2013.10.026 contributor: fullname: Deangelo – volume: 5 start-page: 504 issue: 5 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0535 article-title: Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors publication-title: Cell Stem Cell doi: 10.1016/j.stem.2009.08.018 contributor: fullname: Ikushima – volume: 37 start-page: 3675 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib1230 article-title: TGF-β1 pathway affects the protein expression of many signaling pathways, markers of liver cancer stem cells, cytokeratins, and TERT in liver cancer HepG2 cells publication-title: Tumour Biol. doi: 10.1007/s13277-015-4101-z contributor: fullname: Wang – volume: 30 start-page: 1009 issue: 9 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0775 article-title: Monoclonal antibody therapy directed against human acute myeloid leukemia stem cells publication-title: Oncogene doi: 10.1038/onc.2010.511 contributor: fullname: Majeti – volume: 12 start-page: 329 issue: 3 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0675 article-title: BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells publication-title: Cell Stem Cell doi: 10.1016/j.stem.2012.12.013 contributor: fullname: Lagadinou – volume: 9 start-page: 582 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0055 article-title: Ruthenium complexes with piplartine cause apoptosis through MAPK signaling by a p53-dependent pathway in human colon carcinoma cells and inhibit tumor development in a xenograft model publication-title: Front. Oncol. doi: 10.3389/fonc.2019.00582 contributor: fullname: Baliza – volume: 20 start-page: 1456 issue: 11 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0215 article-title: RBPJ-dependent Notch signaling initiates the T cell program in a subset of thymus-seeding progenitors publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0518-7 contributor: fullname: Chen – volume: 18 start-page: 1926 issue: 16 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib0470 article-title: Upstream and downstream of mTOR publication-title: Genes Dev. doi: 10.1101/gad.1212704 contributor: fullname: Hay – volume: 128 start-page: 2317 issue: 10 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0530 article-title: Inhibition of signal transducer and activator of transcription 5 by the inhibitor of janus kinases stimulates dormant human leukemia CD34+ /CD38- cells and sensitizes them to antileukemia agents publication-title: Int. J. Cancer doi: 10.1002/ijc.25806 contributor: fullname: Ikezoe – volume: 114 start-page: 4359 issue: Pt 24 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0850 article-title: Smad regulation in TGF-beta signal transduction publication-title: J. Cell. Sci. doi: 10.1242/jcs.114.24.4359 contributor: fullname: Moustakas – volume: 73 start-page: 373 issue: 1 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib1145 article-title: STAT5 is crucial to maintain leukemic stem cells in acute myelogenous leukemias induced by MOZ-TIF2 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-12-0255 contributor: fullname: Tam – volume: 105 start-page: 4163 issue: 11 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0440 article-title: The sesquiterpene lactone parthenolide induces apoptosis of human acute myelogenous leukemia stem and progenitor cells publication-title: Blood doi: 10.1182/blood-2004-10-4135 contributor: fullname: Guzman – volume: 14 start-page: 1777 year: 2000 ident: 10.1016/j.critrevonc.2021.103277_bib0595 article-title: The interleukin-3 receptor alpha chain is a unique marker for human acute myelogenous leukemia stem cells publication-title: Leukemia doi: 10.1038/sj.leu.2401903 contributor: fullname: Jordan – volume: 139 start-page: 95 issue: 2 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0305 article-title: Notch inhibitors for cancer treatment publication-title: Pharmacol. Ther. doi: 10.1016/j.pharmthera.2013.02.003 contributor: fullname: Espinoza – volume: 26 start-page: 1174 issue: 6 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0920 article-title: Protein kinase CK2 in hematologic malignancies: reliance on a pivotal cell survival regulator by oncogenic signaling pathways publication-title: Leukemia doi: 10.1038/leu.2011.385 contributor: fullname: Piazza – year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0030 contributor: fullname: American Cancer Society – volume: 35 start-page: 119 issue: 1 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1045 article-title: The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cells publication-title: Leuk. Res. doi: 10.1016/j.leukres.2010.06.024 contributor: fullname: Schwarz – year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib1110 contributor: fullname: Swerdlow – volume: 110 start-page: 5606 issue: 14 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib1340 article-title: Preferential eradication of acute myelogenous leukemia stem cells by fenretinide publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1302352110 contributor: fullname: Zhang – volume: 99 start-page: 1277 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0940 article-title: Targeting acute myeloid leukemia stem cells: a review and principles for the development of clinical trials publication-title: Haematologica doi: 10.3324/haematol.2013.085209 contributor: fullname: Pollyea – volume: 53 start-page: 409 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0090 article-title: The mechanisms of action of PPARs publication-title: Annu. Rev. Med. doi: 10.1146/annurev.med.53.082901.104018 contributor: fullname: Berger – volume: 34 start-page: 1420 issue: 7 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0155 article-title: The Notch signaling pathway as a mediator of tumor survival publication-title: Carcinogenesis doi: 10.1093/carcin/bgt127 contributor: fullname: Capaccione – volume: 463 start-page: 676 issue: 7281 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0860 article-title: TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia publication-title: Nature doi: 10.1038/nature08734 contributor: fullname: Naka – volume: 15 start-page: 315 issue: 4 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0915 article-title: TGF-β increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma publication-title: Cancer Cell doi: 10.1016/j.ccr.2009.02.011 contributor: fullname: Peñuelas – volume: 24 start-page: 2417 issue: 10 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0570 article-title: Disruption of wnt/β-Catenin exerts antileukemia activity and synergizes with FLT3 inhibition in FLT3-Mutant acute myeloid leukemia publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-1556 contributor: fullname: Jiang – volume: 18 start-page: 8 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1090 article-title: The role of the Hedgehog signaling pathway in cancer: a comprehensive review publication-title: Bosn. J. Basic Med. Sci. doi: 10.17305/bjbms.2018.2756 contributor: fullname: Skoda – volume: 9 start-page: 550 issue: 8 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0295 article-title: Targeting PI3K signalling in cancer: opportunities, challenges and limitations publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2664 contributor: fullname: Engelman – volume: 7 issue: 291 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0725 article-title: Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aaa5731 contributor: fullname: Lim – volume: 16 start-page: 455 issue: 3 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0730 article-title: Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-gamma ligands induces apoptosis on human myeloid leukemia cells in vitro publication-title: Ann. Oncol. doi: 10.1093/annonc/mdi077 contributor: fullname: Liu – volume: 577 start-page: 266 issue: 7789 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0765 article-title: HBO1 is required for the maintenance of leukaemia stem cells publication-title: Nature doi: 10.1038/s41586-019-1835-6 contributor: fullname: MacPherson – volume: 307 start-page: 1098 issue: 5712 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib1015 article-title: Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex publication-title: Science doi: 10.1126/science.1106148 contributor: fullname: Sarbassov – volume: 96 start-page: 309 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0360 article-title: Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+ cells in acute myeloid leukemia publication-title: Eur. J. Haematol. doi: 10.1111/ejh.12592 contributor: fullname: Garg – year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib1000 article-title: Targeting RSPO3-LGR4 signaling for leukemia stem cell eradication in acute myeloid leukemia publication-title: Cancer Cell doi: 10.1016/j.ccell.2020.05.014 contributor: fullname: Salik – volume: 28 start-page: 1099 issue: 8 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0400 article-title: ATM mediates constitutive NF-kappaB activation in high-risk myelodysplastic syndrome and acute myeloid leukemia publication-title: Oncogene doi: 10.1038/onc.2008.457 contributor: fullname: Grosjean-Raillard – volume: 4 start-page: 97 issue: 2 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib1300 article-title: The STATs of cancer--new molecular targets come of age publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1275 contributor: fullname: Yu – volume: 185 start-page: 595 issue: 3 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0105 article-title: Safety and efficacy of vismodegib in relapsed/refractory acute myeloid leukaemia: results of a phase Ib trial publication-title: Br. J. Haematol. doi: 10.1111/bjh.15571 contributor: fullname: Bixby – volume: 10 start-page: 556 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0925 article-title: Non-canonical hedgehog signaling pathway in cancer: activation of GLI transcription factors beyond smoothened publication-title: Front. Genet. doi: 10.3389/fgene.2019.00556 contributor: fullname: Pietrobono – volume: 11 start-page: 928 issue: 1 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib1065 article-title: FOXM1 regulates leukemia stem cell quiescence and survival in MLL-rearranged AML publication-title: Nat. Commun. doi: 10.1038/s41467-020-14590-9 contributor: fullname: Sheng – volume: 8 start-page: 147 issue: 2 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0870 article-title: Gli proteins: regulation in development and cancer publication-title: Cells doi: 10.3390/cells8020147 contributor: fullname: Niewiadomski – volume: 114 start-page: 3983 issue: 19 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0480 article-title: Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal publication-title: Blood doi: 10.1182/blood-2009-06-227603 contributor: fullname: Heuser – volume: 5 start-page: 253 issue: 12 year: 2004 ident: 10.1016/j.critrevonc.2021.103277_bib1275 article-title: The Janus kinases (Jaks) publication-title: Genome Biol. doi: 10.1186/gb-2004-5-12-253 contributor: fullname: Yamaoka – volume: 19 start-page: 2628 issue: 21 year: 2000 ident: 10.1016/j.critrevonc.2021.103277_bib0265 article-title: Serine phosphorylation of STATs publication-title: Oncogene doi: 10.1038/sj.onc.1203481 contributor: fullname: Decker – volume: 61 start-page: 5307 issue: 13 year: 2001 ident: 10.1016/j.critrevonc.2021.103277_bib0525 article-title: Mutational analysis of the peroxisome proliferator-activated receptor γ in human malignancies publication-title: Cancer Res. contributor: fullname: Ikezoe – volume: 26 start-page: 650 issue: 4 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib1170 article-title: Modulating the wnt signaling pathway with small molecules publication-title: Protein Sci. doi: 10.1002/pro.3122 contributor: fullname: Tran – volume: 9 start-page: 1358 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1285 article-title: Donor-derived CD123-Targeted CAR t cell serves as a RIC regimen for haploidentical transplantation in a patient with FUS-ERG+ AML publication-title: Front. Oncol. doi: 10.3389/fonc.2019.01358 contributor: fullname: Yao – volume: 7 start-page: 65012 issue: 40 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0560 article-title: Antineoplastic effects and mechanisms of micheliolide in acute myelogenous leukemia stem cells publication-title: Oncotarget doi: 10.18632/oncotarget.11342 contributor: fullname: Ji – volume: 121 start-page: 5015 issue: 25 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib1100 article-title: Deletion of the NF-κB subunit p65/RelA in the hematopoietic compartment leads to defects in hematopoietic stem cell function publication-title: Blood doi: 10.1182/blood-2013-02-486142 contributor: fullname: Stein – volume: 8 start-page: e2797 issue: 5 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib1265 article-title: Disulfiram/copper selectively eradicates AML leukemia stem cells in vitro and in vivo by simultaneous induction of ROS-JNK and inhibition of NF-κB and Nrf2 publication-title: Cell Death Dis. doi: 10.1038/cddis.2017.176 contributor: fullname: Xu – volume: 121 start-page: 384 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1025 article-title: Human acute myelogenous leukemia stem cells are rare and heterogeneous when assayed in NOD/SCID/IL2Rγc-deficient mice publication-title: J. Clin. Invest. doi: 10.1172/JCI41495 contributor: fullname: Sarry – volume: 38 start-page: 308 issue: 1 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1150 article-title: Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms publication-title: J. Experim. Clin. Cancer Res. CR doi: 10.1186/s13046-019-1295-8 contributor: fullname: Tan – volume: 22 start-page: 2454 issue: 18 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib1205 article-title: Hedgehog: functions and mechanisms publication-title: Genes Dev. doi: 10.1101/gad.1693608 contributor: fullname: Varjosalo – volume: 2011 start-page: 428960 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0635 article-title: Wnt/ß-catenin: a new therapeutic approach to acute myeloid leukemia publication-title: Leuk. Res. Treatment contributor: fullname: Kim – volume: 19 start-page: 206 issue: 4 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0370 article-title: Adding oral pioglitazone to standard induction chemotherapy of acute myeloid leukemia: a randomized clinical trial publication-title: Clin. Lymphoma Myeloma Leuk. doi: 10.1016/j.clml.2019.01.006 contributor: fullname: Ghadiany – volume: 39 start-page: 145 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1350 article-title: Installation of a cancer promoting WNT/SIX1 signaling axis by the oncofusion protein MLL-AF9 publication-title: EBioMedicine doi: 10.1016/j.ebiom.2018.11.039 contributor: fullname: Zhang – volume: 11 start-page: 37 issue: 1 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1190 article-title: JAK3 pathway is constitutively active in B-lineage acute lymphoblastic leukemia publication-title: Expert Rev. Anticancer Ther. doi: 10.1586/era.10.203 contributor: fullname: Uckun – volume: 369 start-page: 20 issue: 1 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib1315 article-title: Notch signaling: an emerging therapeutic target for cancer treatment publication-title: Cancer Lett. doi: 10.1016/j.canlet.2015.07.048 contributor: fullname: Yuan – volume: 4 start-page: e312 issue: 1 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib1040 article-title: Phospho-profiling linking biology and clinics in pediatric acute myeloid leukemia publication-title: Hemasphere doi: 10.1097/HS9.0000000000000312 contributor: fullname: Schumich – volume: 114 start-page: E4574 issue: 23 year: 2017 ident: 10.1016/j.critrevonc.2021.103277_bib0035 article-title: Selective regulation of Notch ligands during angiogenesis is mediated by vimentin publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.1703057114 contributor: fullname: Antfolk – volume: 21 start-page: 1 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0095 article-title: Piplartine induces inhibition of leukemia cell proliferation triggering both apoptosis and necrosis pathways publication-title: Toxicol. In Vitro doi: 10.1016/j.tiv.2006.07.007 contributor: fullname: Bezerra – volume: 24 start-page: 7493 issue: 50 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0665 article-title: AKT crystal structure and AKT-specific inhibitors publication-title: Oncogene doi: 10.1038/sj.onc.1209087 contributor: fullname: Kumar – volume: 20 start-page: 182 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0890 article-title: A novel platinum complex containing a piplartine derivative exhibits enhanced cytotoxicity, causes oxidative stress and triggers apoptotic cell death by ERK/p38 pathway in human acute promyelocytic leukemia HL-60 cells publication-title: Redox Biol. doi: 10.1016/j.redox.2018.10.006 contributor: fullname: Oliveira – volume: 124 start-page: 528 issue: 2 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0600 article-title: Positive feedback between NF-κB and TNF-α promotes leukemia-initiating cell capacity publication-title: J. Clin. Invest. doi: 10.1172/JCI68101 contributor: fullname: Kagoya – volume: 25 start-page: 1064 issue: 7 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0205 article-title: T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant publication-title: Nat. Med. doi: 10.1038/s41591-019-0472-9 contributor: fullname: Chapuis – volume: 104 start-page: 11008 issue: 26 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0510 article-title: CD96 is a specific marker of leukemic stem cells in acute human myeloid leukemia publication-title: Proc. Natl. Acad. Sci. U.S.A. doi: 10.1073/pnas.0704271104 contributor: fullname: Hosen – volume: 143 start-page: 367 issue: 3 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0705 article-title: Hedgehog signalling publication-title: Development doi: 10.1242/dev.120154 contributor: fullname: Lee – volume: 117 start-page: 5918 issue: 22 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0945 article-title: Smad4 binds Hoxa9 in the cytoplasm and protects primitive hematopoietic cells against nuclear activation by Hoxa9 and leukemia transformation publication-title: Blood doi: 10.1182/blood-2010-08-301879 contributor: fullname: Quere – volume: 3 start-page: 3261 issue: 21 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0150 article-title: Cranberry A-type proanthocyanidins selectively target acute myeloid leukemia cells publication-title: Blood Adv. doi: 10.1182/bloodadvances.2018026633 contributor: fullname: Bystrom – volume: 127 start-page: 1163 issue: 9 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0475 article-title: LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia publication-title: Blood doi: 10.1182/blood-2015-09-667808 contributor: fullname: Helsmoortel – volume: 94 start-page: 1370 issue: 12 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib1305 article-title: C. miR-106b modulates cancer stem cell characteristics through TGF-β/Smad signaling in CD44-positive gastric cancer cells publication-title: Lab. Invest. doi: 10.1038/labinvest.2014.125 contributor: fullname: Yu – volume: 32 start-page: 4331 issue: 37 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0680 article-title: Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia publication-title: Oncogene doi: 10.1038/onc.2012.469 contributor: fullname: Lainey – volume: 28 start-page: 573 issue: 11 year: 2003 ident: 10.1016/j.critrevonc.2021.103277_bib0790 article-title: Rheb fills a GAP between TSC and TOR publication-title: Trends Biochem. Sci. doi: 10.1016/j.tibs.2003.09.003 contributor: fullname: Manning – volume: 7 start-page: 708 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0625 article-title: TIM-3 is a promising target to selectively kill acute myeloid Leukemia stem cells publication-title: Cell Stem Cell doi: 10.1016/j.stem.2010.11.014 contributor: fullname: Kikushige – volume: 27 start-page: 1548 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0395 article-title: Notch signaling in acute promyelocytic leukemia publication-title: Leukemia doi: 10.1038/leu.2013.68 contributor: fullname: Grieselhuber – volume: 9 start-page: 64 issue: 1 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0770 article-title: Epidermal growth factor receptor is expressed and active in a subset of acute myeloid leukemia publication-title: J. Hematol. Oncol. doi: 10.1186/s13045-016-0294-x contributor: fullname: Mahmud – volume: 72 start-page: 379 issue: 2 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0210 article-title: JNK-induced apoptosis, compensatory growth, and cancer stem cells publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-11-1982 contributor: fullname: Chen – volume: 7 start-page: 606 issue: 8 year: 2006 ident: 10.1016/j.critrevonc.2021.103277_bib0300 article-title: The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1879 contributor: fullname: Engelman – volume: 7 start-page: 21713 issue: 16 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib1130 article-title: Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia publication-title: Oncotarget doi: 10.18632/oncotarget.7964 contributor: fullname: Takam Kamga – volume: 446 start-page: 475 issue: 5 year: 2005 ident: 10.1016/j.critrevonc.2021.103277_bib0275 article-title: NF-kB in development and progression of human cancer publication-title: Virchows Archiv: Int. J. Pathol. doi: 10.1007/s00428-005-1264-9 contributor: fullname: Dolcet – volume: 107 start-page: 1422 issue: 10 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0340 article-title: Small-molecule Hedgehog inhibitor attenuates the leukemia-initiation potential of acute myeloid leukemia cells publication-title: Cancer Sci. doi: 10.1111/cas.13019 contributor: fullname: Fukushima – volume: 327 start-page: 1650 issue: 5973 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib1220 article-title: The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML publication-title: Science doi: 10.1126/science.1186624 contributor: fullname: Wang – volume: 8 start-page: 399 issue: 4 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1225 article-title: Targeting HIF1α eliminates cancer stem cells in hematological malignancies publication-title: Cell Stem Cell doi: 10.1016/j.stem.2011.02.006 contributor: fullname: Wang – volume: 18 start-page: 606 issue: 6 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib1290 article-title: β-Catenin mediates the establishment and drug resistance of MLL leukemic stem cells publication-title: Cancer Cell doi: 10.1016/j.ccr.2010.10.032 contributor: fullname: Yeung – volume: 9 start-page: 513 issue: 5 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib1270 article-title: Ligand activation of peroxisome proliferator-activated receptor gamma induces apoptosis of leukemia cells by down-regulating the c-myc gene expression via blockade of the Tcf-4 activity publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401000 contributor: fullname: Yamakawa-Karakida – volume: 8 start-page: 1403 issue: 11 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib0405 article-title: Wnt signalling in acute myeloid leukaemia publication-title: Cells doi: 10.3390/cells8111403 contributor: fullname: Gruszka – volume: 30 start-page: 395 issue: 1 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0270 article-title: PI-103 sensitizes acute myeloid leukemia stem cells to daunorubicin-induced cytotoxicity publication-title: Med. Oncol. (Northwood, London, England) doi: 10.1007/s12032-012-0395-5 contributor: fullname: Ding – volume: 17 start-page: 412 issue: 4 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0550 article-title: CD93 marks a non-quiescent human leukemia stem cell population and is required for development of MLL-Rearranged acute myeloid leukemia publication-title: Cell Stem Cell doi: 10.1016/j.stem.2015.08.008 contributor: fullname: Iwasaki – volume: 93 start-page: 241 issue: 2 year: 1998 ident: 10.1016/j.critrevonc.2021.103277_bib1165 article-title: PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL publication-title: Cell doi: 10.1016/S0092-8674(00)81575-5 contributor: fullname: Tontonoz – volume: 211 start-page: 1093 issue: 6 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib1215 article-title: Co-inhibition of NF-κB and JNK is synergistic in TNF-expressing human AML publication-title: J. Exp. Med. doi: 10.1084/jem.20130990 contributor: fullname: Volk – volume: 110 start-page: 2880 issue: 8 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib1035 article-title: STAT5 is required for long-term maintenance of normal and leukemic human stem/progenitor cells publication-title: Blood doi: 10.1182/blood-2006-08-039073 contributor: fullname: Schepers – volume: 1 start-page: 89 issue: 2 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0800 article-title: The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients publication-title: Oncotarget doi: 10.18632/oncotarget.114 contributor: fullname: Martelli – volume: 21 start-page: 71 issue: 1 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib1105 article-title: Non-canonical NF-κB signaling pathway publication-title: Cell Res. doi: 10.1038/cr.2010.177 contributor: fullname: Sun – volume: 100 start-page: 336 issue: 3 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0875 article-title: Anti-CD33 chimeric antigen receptor targeting of acute myeloid leukemia publication-title: Haematologica doi: 10.3324/haematol.2014.112748 contributor: fullname: O’Hear – volume: 12 start-page: 3 issue: 1 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1075 article-title: Emerging functions of the EGFR in cancer publication-title: Mol. Oncol. doi: 10.1002/1878-0261.12155 contributor: fullname: Sigismund – volume: 102 start-page: 972 issue: 3 year: 2003 ident: 10.1016/j.critrevonc.2021.103277_bib1255 article-title: Survival of acute myeloid leukemia cells requires PI3 kinase activation publication-title: Blood doi: 10.1182/blood-2002-11-3429 contributor: fullname: Xu – volume: 18 start-page: 1350 issue: 9 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0545 article-title: A PML–PPAR-δ pathway for fatty acid oxidation regulates hematopoietic stem cell maintenance publication-title: Nat. Med. doi: 10.1038/nm.2882 contributor: fullname: Ito – volume: 26 start-page: 344 issue: 4 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib1175 article-title: Haploinsufficiency of Dnmt1 impairs leukemia stem cell function through derepression of bivalent chromatin domains publication-title: Genes Dev. doi: 10.1101/gad.184341.111 contributor: fullname: Trowbridge – volume: 11 start-page: 95 issue: 1 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib0175 article-title: Targeted elimination of leukemia stem cells; a new therapeutic approach in hemato-oncology publication-title: Curr. Drug Targets doi: 10.2174/138945010790031063 contributor: fullname: Cate – volume: 110 start-page: 2659 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib1195 article-title: The novel AML stem cell associated antigen CLL-1 aids in discrimination between normal and leukemic stem cells publication-title: Blood doi: 10.1182/blood-2007-03-083048 contributor: fullname: van Rhenen – volume: 13 start-page: 1979 issue: 8 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0445 article-title: Selective activity of the histone deacetylase inhibitor AR-42 against leukemia stem cells: a novel potential strategy in acute myelogenous leukemia publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-13-0963 contributor: fullname: Guzman – volume: 367 start-page: 645 year: 1994 ident: 10.1016/j.critrevonc.2021.103277_bib0685 article-title: A cell initiating human acute myeloid leukaemia after transplantation into SCID mice publication-title: Nature doi: 10.1038/367645a0 contributor: fullname: Lapidot – volume: 7 start-page: 519 issue: 4 year: 2011 ident: 10.1016/j.critrevonc.2021.103277_bib0220 article-title: The landscape of EGFR pathways and personalized management of non-small-cell lung cancer publication-title: Future Oncol. (London, England) doi: 10.2217/fon.11.25 contributor: fullname: Cheng – volume: 14 start-page: 1236 issue: 12 year: 2012 ident: 10.1016/j.critrevonc.2021.103277_bib0065 article-title: Regeneration-associated WNT signaling is activated in long-term reconstituting AC133bright acute myeloid leukemia cells publication-title: Neoplasia (New York, N.Y.) doi: 10.1593/neo.121480 contributor: fullname: Beghini – volume: 127 start-page: 53 issue: 1 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0280 article-title: An update of current treatments for adult acute myeloid leukemia publication-title: Blood doi: 10.1182/blood-2015-08-604520 contributor: fullname: Dombret – volume: 38 start-page: 1288 issue: 4 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0755 article-title: Targeting GLI1 suppresses cell growth and enhances chemosensitivity in CD34+ enriched acute myeloid leukemia progenitor cells publication-title: Cell. Physiol. Biochem. doi: 10.1159/000443075 contributor: fullname: Long – volume: 105 start-page: 697 issue: 3 year: 2020 ident: 10.1016/j.critrevonc.2021.103277_bib0465 article-title: Concomitant targeting of BCL2 with venetoclax and MAPK signaling with cobimetinib in acute myeloid leukemia models publication-title: Haematologica doi: 10.3324/haematol.2018.205534 contributor: fullname: Han – volume: 24 start-page: 2294 issue: 10 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1030 article-title: Phase ib study of Glasdegib, a hedgehog pathway inhibitor, in combination with standard chemotherapy in patients with AML or high-risk MDS publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-17-2824 contributor: fullname: Savona – volume: 23 start-page: 14 issue: 1 year: 2015 ident: 10.1016/j.critrevonc.2021.103277_bib0185 article-title: Can an oral antidiabetic (rosiglitazone) be of benefit in leukemia treatment? publication-title: Saudi Pharm. J. doi: 10.1016/j.jsps.2013.12.009 contributor: fullname: Cetinkalp – volume: 10 start-page: 34 issue: 4 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1375 article-title: NF-κB promotes the stem-like properties of leukemia cells by activation of LIN28B publication-title: World J. Stem Cells doi: 10.4252/wjsc.v10.i4.34 contributor: fullname: Zhou – volume: 124 start-page: 1777 year: 2014 ident: 10.1016/j.critrevonc.2021.103277_bib0415 article-title: PIM inhibitors target CD25-positive AML cells through concomitant suppression of STAT5 activation and degradation of MYC oncogene publication-title: Blood doi: 10.1182/blood-2014-01-551234 contributor: fullname: Guo – volume: 34 start-page: 1420 issue: 7 year: 2013 ident: 10.1016/j.critrevonc.2021.103277_bib0160 article-title: The Notch signaling pathway as a mediator of tumor survival publication-title: Carcinogenesis doi: 10.1093/carcin/bgt127 contributor: fullname: Capaccione – volume: 125 start-page: 2863 issue: 12 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0050 article-title: Akt-mediated regulation of NFkappaB and the essentialness of NFkappaB for the oncogenicity of PI3K and Akt publication-title: Int. J. Cancer doi: 10.1002/ijc.24748 contributor: fullname: Bai – volume: 11 start-page: 1958 issue: 12 year: 2019 ident: 10.1016/j.critrevonc.2021.103277_bib1135 article-title: Notch signaling molecules as prognostic biomarkers for acute myeloid leukemia publication-title: Cancers doi: 10.3390/cancers11121958 contributor: fullname: Takam Kamga – volume: 21 start-page: 656 issue: 5 year: 2009 ident: 10.1016/j.critrevonc.2021.103277_bib0815 article-title: Akt-dependent and -independent mechanisms of mTOR regulation in cancer publication-title: Cell. Signal. doi: 10.1016/j.cellsig.2009.01.004 contributor: fullname: Memmott – volume: 128 start-page: 5479 issue: 12 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib1055 article-title: Antisense STAT3 inhibitor decreases viability of myelodysplastic and leukemic stem cells publication-title: J. Clin. Invest. doi: 10.1172/JCI120156 contributor: fullname: Shastri – volume: 110 start-page: 163 issue: 2 year: 2002 ident: 10.1016/j.critrevonc.2021.103277_bib0630 article-title: mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery publication-title: Cell doi: 10.1016/S0092-8674(02)00808-5 contributor: fullname: Kim – volume: 7 start-page: 29804 issue: 20 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0410 article-title: Notch signaling: its roles and therapeutic potential in hematological malignancies publication-title: Oncotarget doi: 10.18632/oncotarget.7772 contributor: fullname: Gu – volume: 70 start-page: 4949 issue: 12 year: 2010 ident: 10.1016/j.critrevonc.2021.103277_bib1180 article-title: Role of peroxisome proliferator-activated receptor-gamma and its coactivator DRIP205 in cellular responses to CDDO (RTA-401) in acute myelogenous leukemia publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-09-1962 contributor: fullname: Tsao – volume: 22 start-page: 1698 issue: 9 year: 2008 ident: 10.1016/j.critrevonc.2021.103277_bib0895 article-title: PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML publication-title: Leukemia doi: 10.1038/leu.2008.144 contributor: fullname: Park – volume: 13 start-page: 209 issue: 3 year: 2018 ident: 10.1016/j.critrevonc.2021.103277_bib0255 article-title: The anticancer potential of peroxisome proliferator-activated receptor antagonists publication-title: Chem Med Chem doi: 10.1002/cmdc.201700703 contributor: fullname: De Lellis – volume: 110 start-page: 4427 issue: 13 year: 2016 ident: 10.1016/j.critrevonc.2021.103277_bib0450 article-title: An orally bioavailable parthenolide analog selectively eradicates acute myelogenous leukemia stem and progenitor cells publication-title: Blood doi: 10.1182/blood-2007-05-090621 contributor: fullname: Guzman – volume: 448 start-page: 439 issue: 7152 year: 2007 ident: 10.1016/j.critrevonc.2021.103277_bib0165 article-title: A transforming mutation in the pleckstrin homology domain of AKT1 in cancer publication-title: Nature doi: 10.1038/nature05933 contributor: fullname: Carpten |
SSID | ssj0004467 |
Score | 2.5060759 |
SecondaryResourceType | review_article |
Snippet | •Acute myeloid leukemia remains the most lethal of leukemias.•Leukemic stem cells are associated with disease relapses.•Cell signaling pathways are targets to... Acute myeloid leukemia (AML) remains the most lethal of leukemias and a small population of cells called leukemic stem cells (LSCs) has been associated with... |
SourceID | proquest crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 103277 |
SubjectTerms | Acute myeloid leukemia Cell signaling Humans Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - genetics Leukemic stem cells Neoplastic Stem Cells - metabolism NF-kappa B - metabolism Phosphatidylinositol 3-Kinases Signal Transduction Target therapy |
Title | Cell signaling pathways as molecular targets to eliminate AML stem cells |
URI | https://dx.doi.org/10.1016/j.critrevonc.2021.103277 https://www.ncbi.nlm.nih.gov/pubmed/33716201 https://search.proquest.com/docview/2501483197 |
Volume | 160 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3da9swEBdZB2Mvo_vu2g4N9mZsbMu2HPaUtuny0O4h6WDsxciWXFIye9TOxv773UmyktIVOsZeTCInOXP3y-nudB-EvC_DVMZhGfo84-CgjCX3RS5qX2UlGEmRqjJdKDxb8E9f8pNpMh2NhiFjm7X_KmlYA1lj5exfSNv9KCzAa5A5XEHqcL2X3I8xGIdZGcIUmoOF91P86nCezLdhFK5n8r91cwe10nO9euVNzs88bOvsYTC_27Za3TwE27sUgyRtU9lCl1Pd9_VGeH7eSvD610YFTRph8kqAjHcUeBLeBu7sox3sV1ELtRLex2Dibi6Wqx_C5A7h-ULjnQVzd_NkKayGu7xeSm8eLIKjYDuIEUdbuS86snarukYrY8x2zBNbPK7MWs7xMMc0cHca3IwkuLUbmMDEVQD6twcGAWMCJI6NBmI7POZmr-0FkkSKcaSNM9jbH8agwVCBfk3nm4LbRI8mdg9oU8RM4uCfqd1l99zl12j75mKXPLGOCZ0YRD0lI9U8I4_OberFczJDYFEHLDoAi4qOOmBRCyzat9QBiwKwKAKLamC9IJ9PpxfHM9-O4fArxpPeLwW4ACkTeTZOcCZILbNQqkoxlWeVGksGq3nJRcbjSmaxZDXjeBlHpUrAHWIvyU7TNuo1oaAVwB5SeFieJkxgZ6Q6BZMxVmmVl4nYI9HApOK76bZSDGmIV8WGsQUytjCM3SMfBm4W1mo01mABMLjHt98NAihAsSIfRKPadVfEeOKeww4Fn3llJOOeiTFsvBZGb_6J9j55vPkvHJCd_nqtDsmDTq7farj9BoiPpXU |
link.rule.ids | 315,782,786,27933,27934 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cell+signaling+pathways+as+molecular+targets+to+eliminate+AML+stem+cells&rft.jtitle=Critical+reviews+in+oncology%2Fhematology&rft.au=Rodrigues%2C+Ana+Carolina+B.+da+C.&rft.au=Costa%2C+Rafaela+G.A.&rft.au=Silva%2C+Suellen+L.R.&rft.au=Dias%2C+Ingrid+R.S.B.&rft.date=2021-04-01&rft.pub=Elsevier+B.V&rft.issn=1040-8428&rft.eissn=1879-0461&rft.volume=160&rft_id=info:doi/10.1016%2Fj.critrevonc.2021.103277&rft.externalDocID=S1040842821000652 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1040-8428&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1040-8428&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1040-8428&client=summon |